CURRICULUM
VITAE
August 2007
Joseph C. Cappelleri, Ph.D.,
M.P.H., M.S.
Office:
Pfizer Inc
Global
Research & Development
MS
8260-2222
Eastern
e-mail:
joseph.c.cappelleri@pfizer.com
tel.: (860)
441-8668
fax: (860)
441-8751
EDUCATION
Graduate
1993 M.P.H. (Epidemiology),
1991 Ph.D. (Psychometrics),
1986 M.S. (Statistics), City
Undergraduate
1984 B.B.A.
(Finance), City
WORK EXPERIENCE
Pfizer
Inc, Global Research & Development,
1/04 – present Director,
Statistical Scientist, Biostatistics
12/02 – 12/03 Senior
Associate Director, Statistical Scientist, Biostatistics
2/00
– 11/02 Associate
Director II, Biostatistics
2/98
– 1/00 Associate
Director I, Biostatistics
6/96
– 1/98 Senior
Coordinator, Biostatistics
Provide statistical and
methodological consulting and advising -- manuscripts, presentations, design & analysis,
internal reports, analysis plans, teaching and moderating workshops, collaborations
with clinicians & biostatisticians -- across therapeutic areas and phases
of drug development in health services and outcomes research
8/03 – present Adjunct
Faculty Member in Statistics
Teach semester-long graduate courses on epidemiology and longitudinal analysis
as well as supervise students and collaborate with students
10/96
– present Adjunct
Faculty Member in Medicine
Department
of Medicine, Division of Clinical Care Research,
Collaborate with faculty, supervise students, and lecture
3/93 -
6/96 Research
Associate and Assistant Professor of Medicine
New
England Medical Center and Tufts University School of Medicine, Department
of Medicine, Division of Clinical Care Research, Boston, MA
Involved with the development and management of the Real-Time Meta-Analysis
System -- a systematic approach and computer software to organize,
display, and utilize data from randomized control trials to perform
meta-analysis efficiently -- for pharmaceuticals agents that cover antibiotic
usage, hypertension, congestive heart failure, and AIDS
Involved with meta-analyses to evaluate the efficacy and safety of drugs that cover
infectious (including AIDS), cardiovascular, and cerebrovascular diseases
Involved with statistical and methodological issues in meta-analysis
Presented lectures on meta-analysis to post-doctoral fellows
2/92 -
9/92 Research
Associate, Technology Assessment Group, Harvard School of Public Health,
Boston, MA
Prepared a meta-analysis on the relative efficacy and safety of different
aspirin dosages on vascular events
1/90 -
9/91 Research
Support Specialist
National Data Archive on
Child Abuse & Neglect, Cornell University, Ithaca,
NY
Provided statistical and technical support on the Second National Incidence and
Prevalence
Study of Child Abuse & Neglect
Worked with complex survey data analyzed with the programs WESVAR WESREG,
and WESLOG; used large data tapes, SAS, and the VM/MVS and
VM/CMS computer operating system
2007 Coauthored
article (Allison et al. American Journal of Psychiatry. 1999; 156:1686-1696)
ranked as the sixth most cited article ever in the American Journal of
Psychiatry.
2007 Exceptional
psychometric validation on patient-reported outcomes (including the Erection
Hardness Scale) in erectile dysfunction (Pfizer Inc)
2007
Outstanding
psychometric validation on patient-reported outcomes in obesity (Pfizer Inc)
2007 Interviewed
in Doctor’s Guide to the Internet
article “Sunitinib (Sutent) Improves Quality of Life over Interferon-Alfa
in Kidney Cancer” based on conference presentation.
2006 Interviewed
in Pfizer Press Release on “New Data Suggest Pfizer’s Varenicline
Reduces Craving and Withdrawal Symptoms Associated with Quitting Smoking and
Decreases Satisfaction and Reward from Smoking” for delivering conference
presentations
2006 Interviewed
in Blackwell Publishing Press Release on “Erection Pill Associated with
Normalization of Relationships and Self-Esteem in Men with Erectile
Dysfunction” as lead author on journal article
2006 Leadership,
support, and leadership for the Hierarchical and Survival Models Workshops at
Pfizer Inc
2005 Research
Fellow, Center for Healthcare & Insurance Studies, University of
Connecticut, Storrs, CT
2005 Coauthored
article (Rosenstock et al. Diabetes
Care. 2004; 27:1318-1323)
selected
for the Yearbook of Endocrinology 2005 that brings together abstracts of
articles that reported the year’s breakthrough developments in
endocrinology (In: Mazzaferri EL, ed. Yearbook of Endocrinology 2005.
Philadelphia, PA: Elsevier)
2005 Leadership,
support, and teamwork for the Applied Longitudinal Analysis Workshops at Pfizer
Inc
2005 Leadership
and team building for presenting 5-hour workshop on meta-analysis to Outcomes
Research Group at Pfizer Inc
2005 Statistical
and methodological contributions in developing and validating an instrument for
early onset for patients with generalized anxiety disorder (Pfizer Inc)
2004 Leadership
in and teaching of Item Response Theory Seminar Series to colleagues in
Outcomes Research at Pfizer Inc
2004 Regulatory
support of Femhrt (Pfizer Inc)
2004 Analysis
and strategy in support of Celebrex (Pfizer Inc)
2003 Tireless efforts, enthusiasm, and productive collaborations in
support of Outcomes Research at Pfizer Inc
2003 Psychometric
analyses of data on smoking cessation (Pfizer Inc)
2002 Leadership,
teamwork, and contributions to support Femhrt skin aging program and Zoloft
(Pfizer Inc)
2001 Interviewed
in book “Viagra: The remarkable story of the discovery and launch”
(by Larry Katzenstein, New York: Medical Information Press, 61-62)
2001 Outstanding
performance in teaching Modern Psychometric Workshop and Clinical Significance
Workshop (Pfizer Inc)
2001 Excellence
in overall statistical support to Outcomes Research (Pfizer Inc)
2001 Teamwork
and leadership in support of Biometrics support to Ann Arbor’s Outcomes
Research development (Pfizer Inc)
2001
Major contributions to inhaled
insulin program: Phase 2 (Pfizer Inc)
2001 Major
contributions to inhaled insulin program: Phase 3 (Pfizer Inc)
1995 Special
and Scientific Staff, Tufts University
1991 Cancer
Epidemiology Fellowship, Harvard University
1990 Phi
Kappa Phi, Cornell University Chapter
1986 Rosenkranz-Goldstein
Award for Excellence in Statistics
1984 Magna
Cum Laude
1984 Baruch
Alumni Scholarship
1983 Beta
Gamma Sigma
International
Society for Quality of Life Research
·
Pharmaceutical Research and Manufacturers
of America
·
American Statistical
Association
Drug
Information Association
International
Society for Pharmacoeconomics and Outcomes Research
International
Chinese Statistical Association
Society for
Clinical Trials
Society
for Medical Decision Making
SUBJECTS TAUGHT
·
Instructor
on graduate statistics course “Applied Longitudinal Analysis” to
students at the University of Connecticut, Storrs (spring 2006 semester,
January 17 – April 28).
·
Instructor
on graduate statistics course “Introduction to Epidemiology” to
students at the University of Connecticut, Storrs (spring 2004 semester,
January 20 – April 30; spring 2005 semester, January 18 – April 29;
spring 2007 semester, January 16 – April 27).
·
Instructor
on “An Overview of
Outcomes Research” and “An Overview of the International Index of
Erectile Function” in a managerial statistics seminar at Rensselaer
Polytechnic Institute (three-hour lecture, Groton, Connecticut, November 7,
2003)
·
Instructor on “Applying the
Rasch Model’ (seminar to Pfizer employees, Groton, CT, January - June
2003)
·
Instructor on “Meta-Analysis
and Systemic Literature Review – Introduction” (four-hour short
course at the Annual International Meeting of the International Society for
Pharmacoeconomics and Outcomes Research: Arlington, Virginia, May 20-23, 2001;
May 19-22, 2002; May 18-21, 2003; May 16-19, 2004; Washington, DC, May 15-18,
2005. Pfizer Inc, New London, CT, May 21-22, 2003 and June 22, 2004, Pfizer
Inc, New York, NY, March 29, 2005)
·
Instructor on “Introduction
to Meta-Analysis” in clinical trials course at the University of
Connecticut, Storrs (two 3-hour lectures, April 16 and 23, 2003; 3-hour
lecture, November 15, 2004)
·
Instructor on “Sample Size
Estimation in Outcomes Research” (four-hour short course to Pfizer
employees in Ann Arbor, MI, October 17, 2001; Groton/New London, CT, May 15,
June 21, 2003)
·
Instructor on “Introduction
to Business Statistics” (spring 1987 and summer 1987 to Baruch
undergraduates)
·
Teaching assistant on
“Measurement in Program Evaluation & Research” (fall 1988 to
Cornell graduate students)
·
Teaching assistant on
“Program Evaluation & Research Design” (spring 1989 to Cornell
graduate students)
·
Teaching assistant on
“Statistics and the World We Live In” (spring 1988 to Cornell
undergraduate)
FORMER RESEARCH SUPPORT
Contract: University of Illinois at
Chicago
National
Research and Training Center on Psychiatric Disability Amount: $53,000
Period: 9/1995 - 6/1996
Role: Statistical Consultant
Grant
Title: Comparative Outcomes of Ambulatory Pharmaceutical
Agents
Funding
Agency: Agency for Health Care Policy and Research
Amount:
$1.2 million
Period: 3/1993 - 3/1996
Role: Co-Investigator
EDITORIAL ACTIVITY
2007 Reviewer,
Reading First Impact Study, Interim Report; “No Child Left Behind”
(U.S. Department of Education)
2007 Reviewer,
Addictive Behaviors
2006-2007 Reviewer,
Pharmaceutical Statistics
2001-2007 Reviewer,
Quality of Life Research
1998-2007 Editorial
Board and Reviewer, Drug Information Journal
2005-2007 Editorial
Board and Reviewer, Asian Journal of Andrology
2001-2004,
2006-2007 Reviewer,
Value in Health
2001-2002,
2004-2007 Reviewer,
Medical Care
2004-2007 Reviewer,
International Journal of Impotence Research
2006 Reviewer,
National Evaluation of Early Reading First, “No Child Left Behind” (U.S.
Department of Education)
2006 Reviewer,
Drug and Alcohol Dependence
2006 Reviewer,
Dose Findings in Drug Development (N Ting, editor; NY: Springer-Verlag, 2006)
2005-2006
Reviewer, Clinical Trials
2001, 2004-2006 Reviewer,
Statistics in Medicine
1994, 2000-2003,
2005-2006 Reviewer,
Diabetes Care
2003-2004 Reviewer,
Asian Journal of Andrology
1996-2003 Editorial
Board, Clinical Research and Regulatory Affairs
2003 Reviewer,
Journal of Consulting and Clinical Psychology
1998-2002 Reviewer,
Journal of the American Medical Association
2001 Contributor,
“Instrument Responsiveness,” ISPOR
Lexicon,
2nd Edition
2000 Reviewer,
Evaluation & the Health Professions
2000 Reviewer,
Journal of Statistical Planning and Inference
1999 Reviewer,
Journal of Clinical Oncology
1996 Reviewer,
Journal of Thoracic and Cardiovascular Surgery
1995 Reviewer,
Drug and Therapeutics Bulletin
BIBLIOGRAPHY
Peer-Reviewed Manuscripts
Messerli FH, Pinto L, Tang SSK, Thakker KM,
Cappelleri JC, Sichrovsky T, Dubois RW.
Impact of systemic hypertension on the cardiovascular benefits of statin
analysis – A meta-analysis. American Journal of Cardiology. In press.
Luo X, Doherty J, Cappelleri JC, Frush K.
Role of pharmacopepidemiology in evaluating prescription drug safety in
pediatrics. Current
Medical Research and Opinion. In press.
Mulhall JO, Goldstein I, Bushmakin A,
Cappelleri JC, Hvidsten K. Validation of the Erectile Hardness Score. Journal
of Sexual Medicine. In press.
Cappelleri JC, Althof SE, O’Leary MP,
Glina S, King R, Stecher VJ, Carlsson M, Siegel RL. Clinically meaningful
improvement on the Self-Esteem And Relationship questionnaire in men with
erectile dysfunction. Quality of Life Research. In press.
Hu M, Cappelleri JC, KKG Lan. Applying the
law of iterated logarithm to control type 1 error in cumulative meta-analysis
of binary outcomes. Clinical Trials: Journal of the Society for Clinical
Trials. In press.
Rothman
ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B and the Mayo/FDA
Patient-reported Outcomes Consensus Meeting Group. Patient-reported outcomes:
Conceptual issues. Value in Health. In press.
Frost M, Bonomi AE, Cappelleri JC, Schünemann
HJ, Moynihan TJ, Aaronson N and the Clinical Significance Consensus Meeting
Group. Applying quality of life data formally and systematically into clinical
practice. Mayo Clinic Proceedings. In press.
Cappelleri JC, Bell SS, Siegel
RL. Interpretation of a self-esteem subscale for
erectile dysfunction by cumulative logit model. Drug Information Journal. In
press.
Luo X, Cappelleri JC. A practical guide on
evaluating patient-reported outcomes in clinical trials. Biopharmaceutical
Report. In press.
Cappelleri JC, Bushmakin AG, Baker CL, Merikle
E, Olufade AO, Gilbert DG. Multivariate framework of the Brief Questionnaire of
Smoking Urges. Drug and Alcohol Dependence. 2007; 90:234-242.
Thompson JR, Cappelleri JC, Getter C, Pleil
A, Reichel M, Wolf S. Enhanced interpretation of instrument scales using the
Rasch model. Drug Information Journal. 2007; 41:541-550.
Cappelleri JC, Hvidsten K. Pfizer’commitment to patient-reported
outcomes: Treating to a goal that is meaningful for your patient. Journal of Sexual Medicine. March issue,
2007. Journal outsert for promotional and educational use.
Luo X, Cappelleri JC, Frush
K. A systematic review on the application of pharmacoepidemiology in assessing
prescription drug-related adverse events in pediatrics. Current Medical
Research and Opinion. 2007; 23:1015-1024.
Cappelleri JC, Bushmakin AG,
Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the
Modified Cigarette Evaluation Questionnaire.
Addictive Behaviors. 2007; 32:912-923.
Gilder K, Ting N, Tian
L, Cappelleri JC, Hanumara RC. Confidence intervals on intraclass correlation
coefficients in a balanced two-factor random design. Journal of Statistical
Planning and Inference. 2007; 137:1199-1212.
Althof SE,
O’Leary MP, Cappelleri JC, Crowley AR, Tseng L-J, Collins S. Impact of
erectile dysfunction on confidence, self-esteem, and relationship satisfaction
after 9 Months of sildenafil citrate. Journal of Urology. 2006; 176:2132-2137.
Althof SE, O’Leary MP, Cappelleri JC,
Glina S, King R, Tseng L-J, Bowler JL, on behalf of the SEAR Study Group.
Self-esteem, confidence, and relationships in men treated with sildenafil
citrate for erectile dysfunction. Journal
of General Internal Medicine. 2006; 21:1069-1074.
Althof SE,
O’Leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, King R, RL
Siegel on behalf of the International SEAR Study Group. Sildenafil citrate
improves self-esteem, confidence, and relationships in men with erectile
dysfunction: Results from an international, multi-center, double-blind, placebo-controlled
trial. Journal of Sexual Medicine. 2006; 3:521-529.
Mackey WC, Fleisher LA, Haider S,
Sheikh S, Cappelleri JC, Lee WC, Wang Q, Stephens JM. Perioperative myocardial
ischemic injury in high risk vascular surgery patients: Incidence and clinical
significance in a prospective clinical trial. Journal of Vascular Surgery.
2006; 43:533-538.
O’Leary MP, Althof SE,
Cappelleri JC, Crowley A, Sherman N, and Duttagupta S on behalf of the US SEAR
Study Group. Self-esteem, confidence, and relationship satisfaction in men with
erectile dysfunction treated with sildenafil citrate: A multicenter,
randomized, parallel-group, double-blind, placebo-controlled study in the
United States. Journal of Urology. 2006; 175:1058-1062.
Cappelleri JC, Bell SS, Althof SE,
Siegel RL, Stecher VJ. Comparison between sildenafil-treated subjects with
erectile dysfunction and control subjects on the Self-Esteem And Relationship
questionnaire. Journal of Sexual Medicine. 2006; 3:274-282.
Cappelleri JC, Althof SE, Siegel
RL, Stecher VJ, Tseng L-J, Duttagupta S. Association between the Erectile
Dysfunction Inventory of Treatment Satisfaction and the Self-Esteem And
Relationship questionnaire following treatment with sildenafil citrate for men
with erectile dysfunction. Value in Health. 2005; 8(Supplement 1):S54-S60.
Atkinson MJ,
Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the
Treatment Satisfaction Questionnaire for Medication (TSQM Version II) among
outpatient pharmacy consumers. Value in Health. 2005; 8(Supplement 1):S9-S24.
Cappelleri JC,
Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of
research and clinical experience. International Journal of Impotence Research.
2005; 17:307-319.
Cappelleri JC,
Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Revealing the
multidimensional framework of the Minnesota Nicotine Withdrawal Scale. Current
Medical Research and Opinion. 2005; 21:749-760.
Tian L,
Cappelleri JC. A new approach for interval estimation and hypothesis testing of
a certain intraclass correlation coefficient: the generalized variable method.
Statistics in Medicine. 2004; 23:2125-2135.
Rosenstock J,
Cappelleri JC, Bolinder B, Gerber RA. Patient satisfaction and glycemic control
after 1 year with inhale insulin (Exubera®) in patients with
type 1 or type 2 diabetes. Diabetes Care. 2004; 27:1318-1323.
Cappelleri JC,
Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S. Development and
validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile
dysfunction. International Journal of Impotence Research. 2004; 16:30-38.
Lan KKG, Hu M, Cappelleri JC. Applying the law of iterated logarithm to
cumulative
meta-analysis of a continuous endpoint. Statistica Sinica. 2003; 13:1135-1145.
Rosen RC,
Cappelleri JC, Quirk F, Duttagupta S, Symond T, Althof S. Pfizer’s role
in the development of research tools for sexual medicine. International Journal
of Impotence Research. 2003; 15(3):
Invited journal insert in August issue for promotional and educational use.
Cappelleri JC, Ting N. A
modified large-sample approach to approximate interval estimation for a
particular intraclass correlation coefficient. Statistics in Medicine. 2002;
22:1861-1877.
Althof SE. Cappelleri JC, Shpilsky A,
Stecher V, Diuguid C, Sweeney M, Duttagupta S. Treatment responsiveness of the
Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction.
Urology. 2003; 61:888-893.
Rosen RC, Cappelleri JC,
Gendrano N. The International Index of Erectile Function (IIEF): A state-of-the-science
review. International Journal of Impotence Research. 2002; 14:226-244.
Sloan JA, Aaronson N,
Cappelleri JC, Fairclough DL, Varricchio C, and the Clinical Significance
Consensus Meeting Group. Assessing the clinical significance of single items
relative to summated scores. Mayo Clinic Proceedings. 2002; 77:488-494.
Cappelleri JC, Cefalu WT, Rosenstock J,
Kourides IA, Gerber RA. Treatment satisfaction in type 2 diabetes: A comparison
between an inhaled insulin regimen and a subcutaneous insulin regimen. Clinical
Therapeutics. 2002; 24:552- 564.
Santanello NC, Baker D, Cappelleri JC,
Copley-Merriman K, DeMarinis R, Gagnon JP, Hsuan A, Jackson J, Mahmoud R, Miller D, Morgan
M, Osterhaus J, Tilson H, Willke R. Regulatory issues for health-related
quality of life – PhRMA Health Outcomes Committee Workshop, 1999. Value
in Health. 2002; 5:14-25.
Swift RH, Harrigan EP, Cappelleri JC,
Kramer D, Chandler LP. Validation of the Behavioural Activity Rating Scale
(BARS)™: A novel measure of activity in agitated patients. Journal of
Psychiatric Research. 2002; 36:87-95.
Snyder PJ, Cappelleri JC, Archibald CJ,
Fisk JD. Improved detection of differential information processing speed
deficits between two disease-course types of multiple sclerosis. Neuropsychology. 2001;
15:617-625.
Cappelleri JC, Siegel
RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of
erectile function and the Sexual Health Inventory for Men. Clinical
Therapeutics. 2001; 23:1707-1719.
Cappelleri JC. A brief introduction to
meta-analysis. ISPOR News. 2001; 7:8-9 (August 15).
Gerber RA, Cappelleri JC, Kourides IA,
Gelfand RA. Treatment satisfaction with inhaled insulin in patients with type 1
diabetes: A randomized controlled trial. Diabetes Care. 2001; 24:1556-1559.
Snyder PJ, Cappelleri JC. Information
processing speed deficits may be better correlated with the extent of white
matter sclerotic lesions in multiple sclerosis than previously suspected. Brain
and Cognition. 2001; 46:279-284.
Cappelleri JC,
Gerber RA, Kourides IA, Gelfand RA. Development and factor analysis of a
questionnaire to measure patient satisfaction with injected and inhaled insulin
for type 1 diabetes. Diabetes Care. 2000; 23:1799-1803.
Jovell A,
Cappelleri JC. Evidence of the therapeutic effect of antihypertensive therapy:
meta-analysis and meta-regression of randomized and controlled trials
[Spanish]. Medicina Clinica. 2000; 114 (Suppl 2):28-33.
Cappelleri
JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment
of erectile function and the erectile function domain of the International
Index of Erectile Function. Urology. 2000; 56:477-481.
Rosen RC,
Cappelleri JC, Smith MD, Lipsky J, Peña BM.
Development and evaluation of an abridged, 5-item version of the International
Index of Erectile Function (IIEF) as a diagnostic tool for erectile
dysfunction. International Journal of Impotence Research. 1999; 11:319-326.
Allison DB,
Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced
weight gain: A comprehensive research synthesis. American Journal of
Psychiatry. 1999; 156:1686-1696.
Cappelleri JC,
Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the
erectile function domain of the International Index of Erectile Function.
Urology. 1999; 54:346-351.
Allison DB,
Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, Weiden P, Cheskin
LJ. The distribution of body mass index among individuals with and without
schizophrenia. Journal of Clinical Psychiatry. 1999; 60:215-220.
Cappelleri
JC, Yuh L. Opportunities and challenges for industry and FDA. Biopharmaceutical
Report. 1999; 7:1-12.
Cappelleri JC,
Rosen RC, Smith MD, Quirk F, Maytom MC, Mishra A, Osterloh IH. Some
developments on the International Index of Erectile Function (IIEF). Drug
Information Journal. 1999; 33:179-190.
Cappelleri
JC. Guest editor’s note: Randomized controlled trials and outcomes
research. Drug Information Journal. 1999; 33:177-178.
Schmid CH,
Lau J, McIntosh MW, Cappelleri JC. An empirical study of the effect of the
control rate as a predictor of treatment efficacy in meta-analysis of clinical
trials. Statistics in Medicine. 1998; 17:1923-1942.
Ioannidis
JPA, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and
large trials. Journal of the American Medical Association. 1998; 279:1089-1093.
Bonis PAL,
Ioannidis JPA, Cappelleri JC, Kaplan MM, Lau J. Correlation of biochemical
response to alpha interferon with histological improvement in heptatitis C: A
metaanalysis of diagnostic test characteristics. Hepatology. 1997;
26:1035-1044.
Ioannidis
JPA, Sacks HS, Cappelleri JC, Lau J. Clinical efficacy antiretrovirals changes
in treatment-experienced HIV-infected patients: A metaanalysis. Online Journal
of Current Clinical Trials. 1997 May 15; (Doc. No. 204).
Ioannidis
JPA, Cappelleri JC, Melville B, Sacks HS, Lau J. The relationship between study
design, results and reporting of randomized clinical trials of HIV infection.
Controlled Clinical Trials. 1997; 18:431-444.
Cook JA,
Razzano L, Cappelleri JC. Canonical correlation analysis of residential and
vocational outcomes following psychiatric rehabilitation. Evaluation and
Program Planning. 1996; 19:351-363.
Ioannidis
JPA, Cappelleri JC, Schmid CH, Lau J. Impact of epidemic and individual
heterogeneity on population diversity in clinical trials: An example from
trials of human immunodeficiency virus infection. American Journal of
Epidemiology. 1996; 144:1074-85.
Cappelleri JC,
Ioannidis JPA, Schmid CH, de Ferranti SD, Aubert M, Chalmers TC, Lau J. Large
trials vs meta-analysis of smaller trials: How do their results compare?
Journal of the American Medical Association. 1996; 276:1332-1338.
Ioannidis
JPA, Cappelleri JC, Lau J, Sacks HS, Skolnik PR. Predictive value of viral load
measurements in asymptomatic untreated HIV-1 infection: A mathematical model.
AIDS. 1996; 10:255-262.
Barza M,
Ioannidis JPA, Cappelleri JC, Lau J. Single or multiple daily doses of
aminoglycosides: A meta-analysis. British Medical Journal. 1996; 312:338-45.
Ioannidis
JPA, Cappelleri JC, Skolnik PR, Lau J, Sacks HS. A meta-analysis of the
relative efficacy and toxicity of pneumocystis carinii prophylactic regimens.
Archives of Internal Medicine. 1996; 156:177-188.
Cappelleri
JC, Trochim WMK. Ethical and scientific features of cutoff-based designs.
Medical Decision Making. 1995; 15:387-394.
Cappelleri
JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacy and safety of anticoagulant
and antiplatelet therapy versus anticoagulant therapy after heart valve
replacement: A meta-analysis. American Heart Journal. 1995; 130:547-52.
Ioannidis
JPA, Cappelleri JC, Lau J, Skolnik PR, Melville B, Chalmers TC, Sacks HS. Early
or deferred zidovudine in HIV-infected patients without an AIDS-defining illness.
A meta-analysis. Annals of Internal Medicine. 1995; 122:856-866.
Cappelleri
JC, Lau J, Kupelnick B, Chalmers TC. Efficacy and safety of different aspirin
dosages on vascular diseases: A metaregression analysis. Online Journal of
Current Clinical Trials. 1995; Mar 14 (Doc. No. 174).
Reichardt
CS, Trochim WMK, Cappelleri JC. Reports of the death of the
regression-discontinuity design are greatly exaggerated. Evaluation Review.
1995; 19:39-63.
Cappelleri JC,
Trochim WMK. An illustrative statistical analysis of cutoff-based randomized
clinical trials. Journal of Clinical Epidemiology. 1994; 47:261-270.
Cappelleri
JC, Darlington RB, Trochim WMK. Power analysis of cutoff-based randomized
clinical trials. Evaluation Review.
1994; 18:141-152.
Cappelleri JC,
Eckenrode J, Powers J. The epidemiology of child abuse: Findings from the
second national incidence and prevalence study of child abuse and neglect.
American Journal of Public Health. 1993; 83:1622-1624.
Trochim
WMK, Cappelleri JC. Cutoff assignment strategies for enhancing randomized
clinical trials. Controlled Clinical Trials. 1992; 13:190-212.
Trochim
WMK, Cappelleri JC, Reichardt CS. Random measurement error does not bias the
treatment effect estimate in the regression-discontinuity design: II. When an
interaction effect is present. Evaluation Review. 1991; 15:571-604.
Cappelleri
JC, Trochim WMK, Stanley TD, Reichardt CS. Random measurement error does not
bias the treatment effect estimate in the regression-discontinuity design: I.
The case of no interaction. Evaluation Review. 1991; 15:395-419.
Buchanan
RJ, Cappelleri JC, Ohsfeldt RL. The social environment and Medicaid
expenditures: Factors influencing the level of state Medicaid spending. Public
Administration Review. 1991;
51:67-73.
Cappelleri
JC. Cable TV and reading. New York Statistician. 1988; 40(2):3.
Cappelleri
JC. Classifying methodological and conceptual problems in health statistics.
New York Statistician. 1987;
39(2):2-3.
Cappelleri
JC. Faulty probabilistic interpretation in clinical medicine. New York
Statistician. 1987; 38(5):2-3.
Cappelleri
JC, Rosen HM. An inappropriate mortality rate model. New York Statistician.
1987; 38(3):1-2.
Consensus
Groups
Halynard
MY, Cella D, Jackson JD, Synder CF, Watson ME, and the Mayo/FDA Patient-reported
Outcomes Consensus Meeting Group. Patient-reported outcome instrument
selection: Designing a measurement strategy. Value in Health. In press.
Turner
RR, Cleeland CS, Kallich JD, Parasuraman BM, Quittner AL, and the Mayo/FDA
Patient-reported Outcomes Consensus Meeting Group. Patient-reported outcomes:
Instrument selection issues. Value in Health. In press.
Frost
MH, Hays RD, Liepa AM, Reeve BB, Stauffer JW, and the Mayo/FDA Patient-reported
Outcomes Consensus Meeting Group. What is sufficient evidence for the validity
of patient-reported outcomes? Value in Health. In press.
Sloan
JA, Erickson PA, Guess H, Revicki DA, Santanello NC, and the Mayo/FDA
Patient-reported Outcomes Consensus Meeting Group. Analysis, interpretation,
and reporting results based on patient-reported outcomes. Value in Health. In
press.
Guyatt
G, Ferrans C, Halyard M, Revicki DA, Symonds T, Alonso J, and the Clinical
Significance Consensus Meeting Group. What is the value to the clinician of
health-related quality of life information from clinical research and using QOL
measures in practice?
Mayo
Clinic Proceedings. In press.
Hahn
EA, Cella D, Chassany O, Fairclough D, Wong GY, Hays RD, and the Clinical
Significance Consensus Meeting Group. A guide for clinicians to compare the
precision of health-related quality of life relative to other measures. Mayo
Clinic Proceedings. In press.
Osoba
D, Sprangers M, Wyrwich K, Patrick D, Gorkin L, Richardson III J, and the
Clinical Significance Consensus Meeting Group. The use of quality of life (QOL)
data to support medical decision-making. Mayo Clinic Proceedings. In press.
Sloan
JA, Moinpour C, Berzon R, Bollinger M, Barofsky I, Wu A, and the Clinical
Significance Consensus Meeting Group. The costs of incorporating quality of life
assessments into clinical research: What resources are required? Mayo Clinic
Proceedings. In press.
Sloan J, Frost M, Berzon R,
Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D for the Clinical
Significance Consensus Meeting Group. The clinical significance of quality of
life assessments in oncology: A summary for clinicians. Supportive Care in
Cancer. 23 June 2006. Published online.
Wyrwich KW, Bullinger M,
Aaronson N, Hays RD, Patrick DL, Symonds T & The Clinical Significance
Consensus Meeting Group. Estimating clinically significant differences in
quality of life outcomes. Quality of Life Research 2005; 14:285-295.
Sloan JA, Cella D, Frost MH,
Guyatt G, and Osoba D, for the Clinical Significance Consensus Meeting Group.
Quality of life III: Translating the science of quality-of-life assessment into
clinical practice – An example-driven approach for practicing clinicians
and clinical researchers. Clinical Therapeutics 2003; 25(Suppl. D):D1-D5.
Guyatt G, Ferrans C, Halyard M,
Revicki D, Symonds T, Varricchio C, and Alonso J, for the Clinical Significance
Consensus Meeting Group. What is the value added to the clinician of
health-related quality-of-life information from clinical research and using QOL
measures in clinical practice. Clinical Therapeutics 2003; 25(Suppl D):D6-D7.
Cella D, Chassany O, Fairclough
D, Hahn EA, Hays RD, and Wong G, for the Clinical Significance Consensus
Meeting Group. A guide for clinicians to compare the accuracy and precision of
health-related quality-of-life data relative to other clinical measures.
Clinical Therapeutics 2003; 25(Suppl D):D7-D8.
Osoba D, Sprangers M, Wyrwich
K, Patrick D, Gorkin L, and Richardson III J, for the Clinical Significance
Consensus Meeting Group. The use of health-related quality-of-life data to
support medical decision making. Clinical Therapeutics 2003; 25(Suppl D):D8.
Sloan JA, Moinpour C, Berzon R,
Bullinger M, Barofsky I, and Wu AW, for the Clinical Significance Consensus
Meeting Group. The costs of incorporating quality-of-life assessments into
clinical practice and research: What resources are required? Clinical
Therapeutics 2003; 25(Suppl D):D9.
Frost MH, Bonomi AA, Cappelleri
JC, Schunemann H, Moynihan T, and Aaronson N, for the Clinical Significance
Consensus Meeting Group. Applying quality-of-life data formally and
systematically into clinical practice. Clinical Therapeutics 2003; 25(Suppl
D):D10.
Sloan JA, Cella D, Frost M,
Guyatt GH, Sprangers M, Symonds T, and the Clinical Significance Consensus
Meeting Group. Assessing clinical significance in measuring oncology patient
quality of life: Introduction to the symposium, content overview, and
definition of terms. Mayo Clinic Proceedings. 2002; 77:367-370.
Guyatt GH, Osoba D, Wu AW,
Wyrwich KW, Norman GR, and the Clinical Significance Consensus Meeting Group.
Methods to explain the clinical significance of health status measures. Mayo
Clinic Proceedings. 2002; 77:371-383.
Cella D, Bullinger M, Scott C, Barofsky I, and the Clinical Significance
Consensus Meeting Group. Group vs individual approaches to understanding the
clinical significance of differences or changes in quality of life. Mayo Clinic
Proceedings. 2002; 77:384-392.
Frost MH, Bonomi AE,
Ferrans CE, Wong GY, Hays RD, and the Clinical Significance Consensus Meeting
Group. Patient, clinician and population perspectives on determining the
clinical significance of quality of life scores. Mayo Clinic Proceedings. 2002;
77:488-494.
Sprangers MAG, Moinpour CM,
Moynihan TJ, Patrick DL, Revicki DA, and the Clinical
in quality of life: A users'
guide for clinicians. Mayo Clinic Proceedings. 2002. 77:561-571.
Consensus Meeting Group. The
clinical significance of QOL results: Practical
considerations for specific audiences. Mayo Clinic Proceedings. 2002.
77:572-583.
Letters to the Editor
Sobel
RE, Cappelleri JC. Non-arteritic anterior ischaemic optic neuropathy and the
treatment of erectile dysfunction: reply from Pfizer. British Journal of
Ophthalmology. 2006; 90:927.
Cappelleri
JC, Rosen RC. A
comparison of the International Index of Erectile Function and
erectile dysfunction
studies: reply to Kassouf and Carrie. BJU International. 2003; 92:654.
Rosen RC,
Cappelleri JC. Correspondence. The sexual health inventory for men (IIEF-5):
Reply to Vroege.
International Journal of Impotence Research. 2000; 12:342-343.
Cappelleri JC,
Rosen RC. Correspondence. The sexual health inventory for men (IIEF-5).
International Journal of Impotence Research. 1999; 11:353-354.
Ioannidis
JPA, Cappelleri JC, Lau J. Correspondence. Comparing results from meta-analyses
vs large trials. Journal of the American Medical Association. 1998; 280:518-519.
Ioannidis
JPA, Cappelleri JC, Lau J. Correspondence. Meta-analyses and large randomized,
controlled trials. New England Journal of Medicine. 1998; 338:59.
Cappelleri JC, Ioannidis JPA, Schmid CH, Lau J. Correspondence.
Large trials versus meta-analysis of smaller trials. Journal of the American
Medical Association. 1997; 277:377-378.
Cappelleri
JC. Correspondence. A personal view of some controversies in allocating
treatment to patients in clinical trials. Statistics in Medicine. 1996; 15:113-114.
Ioannidis
JPA, Cappelleri JC, Lau J. Correspondence. Viral load and response to treatment
of HIV. New England Journal of Medicine. 1996; 334:1671.
Conference Proceedings
Cappelleri
JC. Embedding the regression-discontinuity design within the randomized design.
American Statistician Association, 1997 Proceedings of the Biopharmaceutical
Section, pp.290-296.
Schmid CH,
Cappelleri JC, Lau J. Bayesian methods to improve sample size approximations.
American Statistical Association, 1995 Proceedings of the Section on Bayesian
Statistical Sciences, pp. 89-94.
Cappelleri
JC. Coupling outcome pattern matching and program theory with ordinal
categorical methods for the m by 2 ordered contingency table. In: Rinn C.
Proceedings of the 1990 Edward Kelly Evaluation Conference. Albany, New York:
The Evaluation Consortium at SUNY/Albany; 1990:95-109.
Book Reviews
Abramson
JH. Making sense of data: A self-instructional manual on the interpretation of
epidemiological data. New York: Oxford University Press. 1988. Reviewed for
Evaluation Practice. 1990; 11:63-65.
Agresti A.
Analysis of ordinal categorical data.
New York: John Wiley & Sons. 1984. Reviewed for the New York
Statistician. 1987; 38(3):4-5.
Book Chapters
Kamath CC,
Cappelleri JC, Sloan JA. “Clinical Significance of Quality-of-Life
Measures.” In:
Chow S-C,
Liu J-P (coeditors), Encyclopedia of Clinical Trials. New York, NY: John Wiley
& Sons. In press.
Copley-Merriman
K, Jackson J, Boyer JG, Cappelleri JC, DeMarinis R, DiCesare J, Erder MH, Gagnon
JP, Garrison L, Gondek K, Heithoff KA, Hughes T, Miller D, Rothman M,
Santanello N, Willke R, Wong B. “Industry Perspective Regarding Outcomes
Research in Oncology.” In: Lipscomb J, Gotay CC, Snyder C (coeditors),
Outcomes Assessment in Cancer: Measures, Methods, and Applications. New York,
NY: Cambridge University Press; 2005: 623-638.
Schmid CH,
Cappelleri JC, Lau J. “Bayesian Methods to Improve Sample Size
Approximations.” In: Brand L, Johnson ML (coeditors), Methods of
Enzymology 3 (volume 383): Numerical Computer Methods, Part D. San Diego,
California: Elsevier Inc.; 2004: 406-427 (Chapter 17).
Cappelleri
JC. “Pharmacoepidemilogy” and “Responsiveness.” In:
Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW (coeditors).
“Health Care Cost, Quality, and Outcomes: ISPOR Book of
Terms.” Lawrenceville, New
Jersey: International Society for Pharmacoeconomics and Outcomes Research;
2003: 182-184, 214-216.
Cappelleri
JC, Gerber RA. “Exploratory Factor Analysis.” In: Chow S-C
(editor), Encyclopedia
of
Biopharmaceutical Statistics: 2nd edition, Revised and Expanded. New
York, NY: Marcel Dekker, Inc.; 2003: 343-348.
Cappelleri
JC, Ioannidis JPA, Lau, J. “Meta-Analysis of Therapeutic Trials.”
In: Chow S-C (editor), Encyclopedia of Biopharmaceutical Statistics: 2nd
edition, Revised and Expanded. New York, NY: Marcel Dekker, Inc.; 2003:
586-598.
Cappelleri,
JC, Trochim WMK. “Cutoff Designs.” In: Chow S-C (editor),
Encyclopedia of Biopharmaceutical Statistics: 2nd Edition, Revised
and Expanded. New York, NY: Marcel Dekker, Inc.; 2003: 263-269.
Cappelleri,
JC, Ioannidis, JPA, Lau J. “Meta-Analysis of Therapeutic Trials.”
In: Chow S-C (editor), Encyclopedia of Biopharmaceutical Statistics. New York,
NY: Marcel Dekker, Inc.; 1999: 307-316.
Cappelleri, J.C., Trochim, WMK. “Cutoff
Designs.” In: Chow S-C (editor), Encyclopedia of Biopharmaceutical
Statistics. New York, NY: Marcel Dekker, Inc.; 1999: 149-156.
Allison DB,
Cappelleri JC, Carpenter KM. “Design and Analysis of Obesity Treatment
and Prevention Trials.” In: Dalton S (editor), Overweight and Weight
Management: The Health Professional’s Guide to Understanding and
Practice. Gaithersburg, Maryland: Aspen Publishers; 1997:557-597.
In:
Gujarati DN. Basic Econometrics. 4th ed. New York: McGraw-Hill.
2003, p. 592. Results of an unpublished term paper "Predicting a bond
rating: An approach revisited."
In: Berenson ML, Levine DM. Basic Business Statistics:
Concepts and Applications. 3rd ed. Englewood Cliffs, New Jersey: Prentice Hall.
1987, Chapter 18. Solutions to problem sets in Chapter 18, "Index Numbers,
Time Series, and Business Forecasting."
Monographs
Cappelleri
JC (editor). Randomized Controlled Trials and Outcomes Research. Drug
Information Journal 1999; 33(1):177-224.
Colditz
GA, Kazda EK, Cappelleri JC (coeditors). First National Meeting on Research
Synthesis: Applications to Drug Regulatory Policy and Health Care Policy.
Clinical Research and Regulatory Affairs 1996; 13(1):1-64.
Cappelleri
JC, Eckenrode J, Powers JL. A User's Guide for the Second National Incidence
Study on Child Abuse and Neglect. Ithaca, New York: National Data Archive on
Child Abuse and Neglect, Cornell University. 1991.
Theses
Cutoff-based
designs in comparison and combination with randomized clinical trials. Ph.D.
Thesis, Cornell University, May 1991.
A survey
of strategies for ordinal categorical data analysis. M.S. Thesis, City
University of New York (Baruch College), June 1986.
Selected published abstracts (with
known citations)
Cappelleri JC, Althof SE, Glina S, King R, Stecher VJ, Carlsson M, Siegel
R. Clinically meaningful improvement on the Self-Esteem And Relationship (SEAR)
questionnaire in men with erectile dysfunction. Journal of Sexual Medicine.
2007; 4 (Supplement 1):85.
Nurnberg HG, Siegel RL, Cappelleri JC. Improved depression severity by
sildenafil treamtent of erectile dysfunction associated with treated or
untreated major depressive disorder. Journal of Sexual Medicine. 2007; 4
(Supplement 1):92-93.
Cappelleri JC, Nurnberg HG, Tseng L-J, Tellier C, Siegel RL. Efficacy of sildenafil for the
treatment of erectile dysfunction in men taking antidepressant medication:
Meta-analysis of randomized, double-blind, placebo-controlled studies. Journal
of Andrology. 2006; March/April Supplement:64.
Messerli
FH, Pinto L, Tang S, Thakker KM, Cappelleri JC, Sichrovsky T, Dubois R.
Does the presence of hypertension affect cardiovascular benefits of statin?
Results from a meta-regression analysis of 69,984 patients. Journal of the
American College of Cardiology. 2006; 47[4 (suppl1)]:371A.
Cappelleri JC, Bushmakin AG, Baker CL,
Merikle E, Olufade AO, Gilbert DG. Confirmatory
factor analysis and reliability of the “Smoking Effects Inventory.”
Value in Health. 2005; 8(3):333-334.
Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade
AO, Gilbert DG. Confirmatory validation of the Brief Questionnaire of Smoking
Urges. Value in Health. 2005; 8(3):334.
Cappelleri JC, Glina S, Duttagupta S, Sherman N, Stecher V,
Siegel R, Tseng L. Assessing responsiveness of the Self-Esteem And Relationship
questionnaire in men with erectile dysfunction treated with Viagra®
(sildenafil citrate) in an international, double-blind, placebo-controlled
trial. Medical Decision Making. 2005; 25(1):E52.
Lee WC, Cappelleri JC,
Sheikh S, Haider S, Gold KF, Stephens JM. Using a pattern mixture model to
understand the impact of non-random missing data in health-related quality of
life among patients undergoing non-cardiac vascular surgery. Value in Health.
2004; 7:708.
Takei
M, Takamoto H, Glina S, Cappelleri JC, Duttagupta S, Sherman N, Stecher VJ,
Siegel R, Tseng L-J. Relationship between erectile functioning and psychosocial
functioning following treatment with Viagraâ
(sildenafil citrate): Results from an international trial. Quality of Life
Research. 2004; 13:1558.
Cappelleri JC, Althof SE,
O’Leary MP, Duttagupta S, Bowler J, Crowley AR, Siegel RL, Tseng L-J,
Glasser DB. Assessing self-esteem, confidence, and relationships in men with
erectile dysfunction treated with sildenafil citrate: Combined analysis of 2
double-blind placebo-controlled trials. Pharmacoepidemiology and Drug Safety.
2004; 13:S139-S140.
Cappelleri JC,
O’Leary MP, Althof SE, Duttagupta S, Sherman N, Crowley AR, Siegel R,
Tseng L-J, Glasser DB. Responsiveness of the Self-Esteem And Relationship
questionnaire in men with erectile dysfunction treated with sildenafil citrate
in a double-blind, placebo-controlled trials. Pharmacoepidemiology and Drug
Safety. 2004; 13:S218.
Lau DT, Cappelleri JC,
Morlock R, Feltner D. Comparing psychometric properties of self-versus
interview-rated instruments used in clinical trials for patients with anxiety
disorders. Value in Health. 2004; 7(3):286.
Treglia M, Bushmakin A,
Siddiqi S, Cappelleri JC. How cognitive function affects activities of daily
living in patients with Alzheimer’s Disease. Value in Health. 2004;
7(3):288.
Harnett J, Enuha S, Xuan
J, Cappelleri J. A meta-analysis of three-day azithromcyin therapy versus
longer courses of comparator antibiotics in acute sinusitis. Value in Health.
2004; 7(3):352.
Cappelleri JC, Duttagupta
S, Sherman N, Stecher VJ, Siegel RL, Tseng L, Glina S. Self-esteem, confidence,
and relationships in men with erectile dysfunction treated with sildenafil: An
international study. Journal of General Internal Medicine. 2004; 19(Supp
1):209.
Cappelleri JC, Duttagupta
S, Sherman N, Siegel RL, Crowley A, Tseng L, O’Leary M, Althof SE.
Self-esteem, confidence, and relationships in men with erectile dysfunction
treated with sildenafil citrate. Journal of General Internal Medicine. 2004;
19(Supp 1):209-210.
Cappelleri JC, Bell SS,
Duttagupta S. Using ordinal logistic regression to enhance interpretation of
health status measures: An application of the Self-Esteem and Relationship
questionnaire for men with erectile dysfunction. Clinical Therapeutics. 2003;
25(Suppl D):D28-D29.
Cappelleri JC, Gerber RA,
Abetz L, Quattrin T. Development and validation of the Children with Diabetes
Questionnaire - a questionnaire to assess treatment satisfaction and
well-being. Diabetes 2003; 52(Suppl 1):1737-P. Diabetes & Metabolism. 2003;
29:4S7-4S428.
Gerber RA, Cappelleri JC,
Abetz L, Quattrin T. Development and validation of the
Parents of Children with Diabetes Questionnaire - a questionnaire to assess treatment
satisfaction and well-being. Diabetes 2003; 52(Suppl1):2433-PO. Diabetes & Metabolism. 2003;
29:4S7-4S428.
Lustig SP, Reichel MB, Cappelleri J,
Clouse B, Getter CA, Chisholm JA. A baseline assessment of the validity of the
39-item National Eye Institute Visual Function Questionnaire in German patients
with age-related macular degeneration. Value in Health. 2003; 6(3):240.
Treglia M, Clouse B, Cappelleri J.
Assessing behavorial functioning in Alzheimer’s Disease: Benchmarking
with the BEHAVE-AD-FW. Value in Health. 2003; 6(3):281.
Cappelleri JC, Duttagupta S, Shpilsky AB,
Diuguid C, Stecher VJ, Sweeney M, Althof SE. Correlating scores on the Erectile
Dysfunction Inventory of Treatment Satisfaction (EDITS) with the Self-Esteem
And Relationship (SEAR) Questionnaire following treatment with Viagra®
(sildenafil citrate) for men with erectile dysfunction: Results from a
multicenter open-label study. Quality of Life Research. 2002; 11(7):668
[Abstract #189].
Althof SE, Cappelleri JC, Shpilsky AB,
Duttagupta S, Stecher VJ, Diuguid C, Sweeney M. Responsiveness of the
Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction (ED).
Quality of Life Research. 2002; 11(7):664 [Abstract # 171].
Cappelleri JC, Bell
SS, Stecher V, Duttagupta S, Diuguid C, Sweeney M. Development and validation of Self-Esteem/Overall
Relationship Questionnaire (SEORQ) in erectile dysfunction. Pharmacoepidemiology and Drug Safety. 2002; 11(suppl
1):S122 [Abstract #261].
Gerber
RA, Cappelleri JC, Nadkarni S, Petrie CD, Rosenstock J. Balancing compliance, patient
satisfaction and improved glycemic control in patients with type 1 and type 2
diabetes mellitus: long-term
studies with inhaled insulin (Exubera).
Diabetologia. 2002; 45 (Suppl 1):A751.
Cappelleri
JC, Gerber RA, Mishra AK. Using the Mann-Whitney statistic to improve the
interpretation of ordinal scales: An application to the Patient Satisfaction
with Insulin Therapy Questionnaire. Quality of Life Research. 2001; 10(3):276
[Abstract # 335].
Cappelleri JC, Gerber
RA, Rosenstock J, Nadkami S, Petrie CD, Kourides IA. Improved patient satisfaction is associated with
inhaled insulin and improved glycemic control: Results from two multi-center
randomized controlled trials. Diabetes.
2001; 50 (Suppl 2):A108.
Cappelleri JC, Gerber RA, Kourides IA,
Gelfand RA. Improved patient satisfaction with
inhaled insulin in subjects with type 1 diabetes mellitus after one year:
Results from a multicenter extension trial. Annales-d'Endocrinologie
(Ann Endocrinol). Novembre 2000; 61(5):464-465.
Lustig SP, Shaw AR,
Cappelleri JC, Vazquez-Abad M-D. The WOMAC discriminates between patients with
mild and severe osteoarthritis. Arthritis & Rheumatism. 2000; 43(9):S110
[Abstract #261].
Woodworth TG,
Mackillop N, Edwards M, Vazquez-Abad M-D, Shaw AR, Cappelleri JC, Ting N,
Buckland-Wright C, Lustig S. Relationship between changes in joint space width
(JSW) and c-reactive protein (CRP), clinical assessments, and health-related
quality of life (HRQoL) instruments in mild/moderate osteoarthritis (OA).
Arthritis & Rheumatism. 2000; 43(9):S222 [Abstract #931].
Gerber RA,
Cappelleri JC, Bell-Farrow AD, English JS, Agramonte RF, Gelfand RA. Improved
patient satisfaction with inhaled insulin in subjects with type 1 diabetes
mellitus after one year: Results from a multicenter extension trial. Diabetes.
2000; 49(Suppl 1):A108.
Cappelleri
JC, Selker HP, Schmid CH, Chalmers TC, Lau J. Applying the “real-time
meta-analysis system” to randomized control trials of congestive heart
failure. Controlled Clinical Trials. 1995; 16(3S):62S.
Schmid CH,
Cappelleri JC, Lau J. Applying Bayesian meta-regression to studies of
thrombolytic therapy. Clinical Research. 1994; 42(2):290a.
Presentations Delivered Personally
2007 Statistical
issues and novel models for quantifying the effects of continuous traits on
mortality: Examples from obesity. Discussant at an invited session, Joint
Statistical Meetings, Salt Lake City, Utah, July 29-August 2.
2007 Using the Rasch
model to enhance interpretation of the Functional Assessment of Cancer
Therapy-Kidney Symptom Index-Disease Related Symptoms (FKSI-DRS). Poster
presentation at the 12th Annual International Meeting of the
International Society for Quality of Life Research, Budapest, Hungary, June
24-26.
2007
Measuring sildenafil effects
on erectile function and antidepressant-treated or untreated depression:
Meta-analysis of randomized treatment studies. Podium poster presentation at
the Annual Meeting of the American Urological Association, Anaheim, California,
May 19-24.
2007 Statistical methods
appropriate for determining efficacy onset: Measuring onset of antidepressant
action in clinical trials. Invited oral presentation at the Onset of Efficacy
Consensus Conference, Washington, DC, April 19.
2007 Tutorial on longitudinal data. Invited presentation at
the Fifth Annual American Statistical Association Connecticut Chapter
Mini-Conference, New Haven, Connecticut, March 31.
2007
An overview of regression-discontinuity designs. Invited oral
presentation at the University of Connecticut, Storrs, Connecticut, February 23.
2007 Effects
of sunitinib versus interferon-alfa on health-related quality of life in
patients with metastatic renal cell cariconoma (mRCC); Comparing the results of
mixed-effects and pattern mixture models. Oral and poster presentations at the
18th International Congress on Anti Cancer Treatment, Paris, France,
February 6-9.
2006 Clinically
meaningful improvement on the Self-Esteem And Relationship (SEAR) questionnaire
in men with erectile dysfunction. Oral and poster presentations at the Sexual
Medicine Society of North America Fall Meeting, Las Vegas, Nevada, November
2-5.
2006 Efficacy
of sildenafil for the treatment of erectile dysfunction in men with depression:
Meta-analysis of randomized, double-blind, placebo-controlled trials. Oral and
poster presentations at the Sexual Medicine Society of North America Fall
Meeting, Las Vegas, Nevada, November 2-5.
2006 The effects of
varenicline, a novel selective alpha 4 beta 2 receptor partial agonist, in
reducing the craving and withdrawal effects associated with smoking cessation.
Poster presentation at the 13th World Conference on Tobacco OR
Health, Washington, DC, July 12-15.
2006 The
effects of varenicline, a novel selective alpha 4 beta 2 nicotinic receptor
partial agonist, on the reinforcing and rewarding effects of smoking. Poster
presentation at the 13th World Conference on Tobacco OR Health,
Washington, DC, July 12-15.
2006 Large
trials vs. meta-analysis of smaller trials: Implications to evidence-based
medicine. Invited oral presentation at the 15th Annual Applied Statistics Symposium of the
International Chinese Statistical Association, Storrs, Connecticut, June 14-17.
Invited oral presentation at the Institute of
Medicine’s Clinical Research Roundtable (What is evidence based medicine
and how do we get there?), Washington, D.C., December 12-13, 2000.
2006 Efficacy
of sildenafil for the treatment of erectile dysfunction in men taking
antidepressant medication: Meta-analysis of randomized, double-blind,
placebo-controlled studies. Podium presentation at the 159th Annual
Meeting of the American Psychiatric Association, Toronto, Canada, May 20-25.
Poster presentation at the 31st Annual Meeting of the American
Society of Andrology, Chicago, Illinois, April 8-11.
2006 Overview of new & enhanced
technologies to enhance PRO collection & management. Invited discussant at
the Patient Reported Outcomes Research Conference, Washington, DC, April 24-25.
2006 New FDA draft guidance document review
and dissemination on patient reported outcomes. Invited workshop presenter at
the Patient Reported Outcomes Research Conference, Washington, DC, April 24-25.
2006 Patient-reported outcomes:
Conceptual issues. Invited oral plenary presentation and coauthored draft
manuscript at the Mayo Clinic/FDA meeting on FDA Guidance on Patient Reported
Outcomes, Chantilly, Virginia, February 23-25.
2006 Effect of varenicline on craving
and withdrawal symptoms. Oral presentation at the
the
12th Annual Meeting of the Society for Research on Nicotine and
Tobacco, Orlando, Florida, February 15-18.
2006 Effect of varenicline on
reinforcing effects associated with smoking. Poster presentation at the 12th
Annual Meeting of the Society for Research on Nicotine and Tobacco, Orlando,
Florida, February 15-18.
2005-6 Using
the cumulative logit model to enhance interpretation of health status measures:
An application to the Self-Esteem And Relationship questionnaire for men with
erectile dysfunction. Oral presentation at the Joint
Statistical Meetings, Minneapolis, Minnesota, August 7-11, 2005; invited
colloquium presentation at the University of Connecticut, Department of
Statistics, Storrs, CT, March 13, 2006.
2005 A modified large-sample approach to
approximate interval estimation for a particular intraclass correlation
coefficient. Invited oral presentation at the Connecticut Chapter Meeting of
the American Statistical Association and at Yale University, New Haven,
Connecticut, November 15.
2005 Evaluating the sample invariance
property of the standard error of measurement. Oral presentation at the 6th
International Conference on Health Policy Research: Methodological Issues in
Health Services and Outcomes Research, Boston, Massachusetts, October 28-30.
2005
A
comparison of two confidence interval approaches for the dependability
coefficient in
a two-factor crossed design. Invited oral presentation at the Applied
Statistics Symposium of the International Chinese Statistical Association,
Bethesda, Maryland, June 12-15.
2005
Sildenafil: Improved erectile function associated with gains in
self-esteem. Poster presentation at the 158th Annual Meeting of the
American Psychiatric Association, Atlanta, Georgia, May 21-26.
2005 Meta-analysis and systemic literature
review – Introduction. Faculty member and instructor for 4-hour short
course at the 10th Annual International Meeting of the International
Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, May
15-18.
2005 Confirmatory validation of the
Brief Questionnaire of Smoking Urges. Poster presentation at the 10th
Annual Meeting of the International Society for Pharmacoeconomics and Outcomes
Research, Washington, DC, May 15-18.
2005 Confirmatory factor analysis and
reliability of the “Smoking Effects Inventory.” Poster presentation
at the 10th Annual Meeting of the International Society for
Pharmacoeconomics and Outcomes Research, Washington, DC, May 15-18.
2005 Utilize patient reported outcomes
to lend meaning to drug benefit. Invited oral presentation at the Center for
Business Intelligence’s Forum on Early Stage Commercialization Strategies
for the Pharmaceutical Industry. Philadelphia, Pennsylvania, April 21-22.
2004-5 Using
CART to develop a diagnostic tool for erectile dysfunction. Invited oral
presentations at CART Data Mining 2005, New York, New York, March 30; CART Data
Mining 2004, San Francisco, California, March 22-24, and at the Second Annual
CT ASA Statistics Mini-Conference, Wallingford, Connecticut, March 13, 2004.
2004 Assessing
responsiveness of the Self-Esteem And Relationship questionnaire in men with
erectile dysfunction treated with Viagraâ (sildenafil citrate) in an international,
double-blind, placebo-controlled trial. Poster presentation at the 26th
Annual Meeting of the Society for Medical Decision Making, Atlanta, Georgia,
October 17-20.
2004 Viagra
case study – Measuring meaningful change in patient reported outcomes.
Invited workshop presentation at the Center for Business Intelligence’s 5th
Annual Forum on Phase IV Clinical Trials. Philadelphia, Pennsylvania, September
20-21.
2004 Responsiveness
of the Self-Esteem And Relationship questionnaire in men with erectile
dysfunction treated with sildenafil citrate in a double-blind,
placebo-controlled trial. Poster presentation at the 20th
International Conference on Pharmacoepidemilogy and Therapeutic Risk
Management, Bordeaux, France, August 22-25.
2004 Assessing
self-esteem, confidence, and relationships in men with erectile dysfunction
treated with sildenafil citrate: Combined analysis of 2 double-blind,
placebo-controlled trials. Oral presentation at the 20th
International Conference on Pharmacoepidemilogy and Therapeutic Risk
Management, Bordeaux, France, August 22-25.
2004 Applying
the law of iterated logarithm to cumulative meta-analysis. Invited oral
presentation at the Joint Statistical Meetings, Toronto, Canada, August
8-12.
2004 Session
on Advanced Statistical Analysis I: Discussion. Discussant – invited oral
presentation at the International Society for Quality of Life Research 2004
Symposium, Boston, MA, June 27-29.
2004 Linking
self-esteem, confidence, and relationships with severity of erectile
dysfunction. Poster presentation at the International Society for Quality of
Life Research 2004 Symposium, Boston, MA, June 27-29.
2004 Self-esteem,
confidence, and relationships in men with erectile dysfunction treated with
sildenafil citrate: combined analysis of 2 double-blind, placebo-controlled
trials. Poster presentations at the International Society for Quality of Life
Research 2004 Symposium, Boston, MA, June 27-29, and at the Drug Information
Association 40th Annual Meeting, Washington, DC, June 13-17.
2004 Meta-analysis
and systemic literature review – Introduction. Faculty member and instructor
for 4-hour short course at the Ninth Annual International Meeting of the
International Society for Pharmacoeconomics and Outcomes Research, Arlington,
Virginia, May 16-19.
2004 Self-esteem,
confidence, and relationships in men with erectile dysfunction treated with
sildenafil citrate. Poster presentation at the 27th Annual Meeting
of the Society of General Internal Medicine, Chicago, Illinois, May 12-15.
2004 Self-esteem,
confidence, and relationships in men with erectile dysfunction treated with sildenafil:
An international study. Poster presentation at the 27th Annual
Meeting of the Society of General Internal Medicine, Chicago, Illinois, May
12-15.
2004
Comparison between sildenafil-treated patients with erectile dysfunction
and control subjects on the Self-Esteem And Relationship (SEAR) questionnaire.
Oral (podium) presentation at the 5th Annual Drug Information
Association Workshop on Pharmaceutical Outcomes Research, Tucson, Arizona,
January 21-23.
2003-4 Using
ordinal logistic regression to enhance interpretation of health status
measures: An application to the Self-Esteem And Relationship questionnaire for
men with erectile dysfunction. Invited
seminar presentation at Tufts-New England Medical Center, Boston,
Massachusetts, July 29, 2004. Poster presentation at Quality of Life III:
Translating the Science of QOL Assessment into Clinical Practice, Scottsdale,
Arizona, October 2-4, 2003.
2002-4 Methods
to explain clinical significance of health status measures.
Invited
oral presentations at the 2nd Annual Pharmaceutical Outcomes
Research Conference,
Washington, D.C., February 23-24, 2004; Use Outcomes Research for Marketplace
Positioning, Philadelphia, Pennsylvania, March 17-18, 2003; and Tufts-New
England Medical Center, Boston, Massachusetts, July 9, 2002. Oral presentation at the International
Conference on Health Policy Research: Methodological
Issues in Health Services and Outcomes Research, Chicago, Illinois, October 17-19, 2003.
2003
Development and validation of the Self-Esteem And Relationship (SEAR)
questionnaire in erectile dysfunction. Oral seminar presentation at University
of Connecticut Health Center, Farmington, Connecticut, December 2.
2003 Applying
quality of life data formally and systematically into clinical practice.
Invited oral plenary presentation at Quality of Life III: Translating the
Science of QOL Assessment into Clinical Practice, Scottsdale, Arizona, October
2-4
2003 Development
and validation of the Children with Diabetes Questionnaire – a questionnaire
to assess treatment satisfaction and well-being. Poster presentation at the
18th
International Diabetes Federation Congress, Paris, France, August 24-29
2003 Methods
for assessing clinical significance in quality of life measurement. Oral presentation
at the Joint Statistical Meetings, San Francisco, California, August 3-7.
2003 An
overview of the International Index of Erectile Function (IIEF). Oral seminar presentation at
Tufts-New England Medical Center, Boston, Massachusetts, July 30.
2003 Development
and validation of the Parents of Children with Diabetes Questionnaire – a
questionnaire to assess treatment satisfaction and well-being. Poster
presentation at the
American
Diabetes Association's 63rd Scientific Sessions, New Orleans, Louisiana, June
13-17. Poster presentation at the 18th International Diabetes
Federation Congress, Paris, France, August 24-29.
2003 A
baseline assessment of the validity of the 39-item National Eye Institute
Visual Function Questionnaire in German patients with age-related macular
degeneration. Poster presentation at the Eight Annual International Meeting of
the International Society for Pharmacoeconomics and Outcomes Research,
Arlington, Virginia, May 18-21. (Finalist for best poster presentation.)
2003 Meta-analysis
and systemic literature review – Introduction. Faculty member and
instructor for 4-hour short course at the Eight Annual International Meeting of
the International Society for Pharmacoeconomics and Outcomes Research,
Arlington, Virginia, May 18-21.
2002
An overview of cutoff designs. Invited oral presentation at the
Tufts-New England Medical Center, Boston, Massachusetts, June 27.
2002 Using
meta-analysis to explore differences in study effects. Oral presentation (guest
faculty) at the Ninth Annual Biopharmaceutical Applied Statistics Symposium,
Savannah, Georgia, December 9-13.
2002 Some
developments on the International Index of Erectile Function (IIEF). Oral
seminar presentation at Brown University School of Medicine, Department of Community
Health, Providence, Rhode Island, November 13.
2002 Correlating
scores on the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS)
with the Self-Esteem And Relationship (SEAR) Questionnaire following treatment
with Viagra® (sildenafil citrate) for men with erectile
dysfunction: Results from a multicenter open-label study. Poster presentation
at the 9th Annual Meeting of the International Society of Quality of
Life Research, Orlando, Florida, October 30-November 2.
2002 Responsiveness
of the Self-Esteem And Relationship (SEAR) questionnaire in erectile
dysfunction (ED). Poster presentation at the 9th Annual Meeting of
the International Society of Quality of Life Research, Orlando, Florida,
October 30-November 2.
2002 Development,
psychometric validation, and treatment responsiveness of the Self-Esteem And
Relationship (SEAR) questionnaire in erectile dysfunction. Oral presentation at
the Fourth Annual Drug Information Association Workshop on Pharmaceutical
Outcomes Research, Newport, Rhode Island, October 16-18.
2002 Beyond
the simple average: Adjusting for heterogeneity and bias in meta-analysis.
Discussant – oral presentation at the Joint Statistical Meetings, New
York, NY, August 11-15.
2002 Meta-analysis
and systemic literature review – Introduction. Faculty member and
instructor for 4-hour short course at the Seventh Annual International Meeting
of the International Society for Pharmacoeconomics and Outcomes Research,
Arlington, Virginia, May 19-22.
2002 Applying
the law of iterated algorithm to cumulative meta-analysis of continuous
outcomes. Oral presentation at the Mathematical Sciences Research
Institute’s Symposium on Statistical Challenges for Meta-Analysis of
Medical and Health-Policy Data. Berkeley, California, May 9-11.
2002 Single
item versus summated scale scores. Invited oral plenary presentation and
participated in panel discussion at Assessing Clinical Significance for Quality
of Life Measures in Oncology Research: State-of-the-Science. Rochester,
Minnesota, April 5-6.
2002 Bayesian
methods in cost-effectiveness analysis: Discussion. Discussant – invited
oral presentation at the Drug Information Association workshop on Innovative
Statistical Strategies in Today’s Environment. Hilton Head, South
Carolina, March 10-12.
2001 A modified large sample approach to approximate
interval estimation for a certain intraclass correlation coefficient. Oral
presentation at the International Conference on Health Policy Research:
Methodological Issues in Health Services and Outcomes Research, Boston,
Massachusetts, December 7-9.
2001 Using the Mann-Whitney
statistic to improve the interpretation of ordinal scales: An application to
the Patient Satisfaction with Insulin Therapy questionnaire. Poster
presentation at the 8th Annual Conference of the International
Society for Quality of Life Research, Amsterdam, The Netherlands, November
7-10.
2001 Assessing
the clinical significance of single items relative to summated scores. Invited
oral presentation at the 8th Annual Conference of the International
Society for Quality of Life Research, Amsterdam, The Netherlands, November
7-10.
2001 A
brief introduction to meta-Analysis. Oral presentation given at the panel
session on Frontiers in Meta-Analysis, Sixth Annual International Meeting of
the International Society for Pharmacoeconomics and Outcomes Research,
Arlington, Virginia, May 20-23.
2001 Meta-analysis
and systemic literature review – Introduction. Faculty member and
instructor for 4-hour short course at the Sixth Annual International Meeting of
the International Society for Pharmacoeconomics and Outcomes Research,
Arlington, Virginia, May 20-23.
2001 Correlation
between patient self-assessment of erectile function and the International
Index of Erectile Function (IIEF-5). Oral presentation at the 154th
Annual Meeting of the American Psychiatric Association, New Orleans, Louisiana,
May 5-10.
2000 Opportunities
for and in outcomes research. Oral presentation as part of the Fall Lecture
Series in the Clinical Research Graduate & Training Program, Tufts-New
England Medical Center, Boston, Massachusetts, December 6.
2000 Meet
the developers session: The International Index of Erectile Function (IIEF).
7th Annual Conference of the International Society for Quality of Life Research
(ISOQOL), Vancouver, Canada, October 29-31.
2000
Improved patient satisfaction with
inhaled insulin in subjects with type 1 diabetes mellitus after one year:
Results from a multicenter extension trial. Invited oral presentation at the 11th
Biennial Meeting of the International Study Group on Innovative Insulin
Delivery, Evian, France, September 13-16.
2000
Inhaled insulin improves
satisfaction with treatment in type 1 patients: A randomized controlled trial.
Invited oral presentation at the 11th Biennial Meeting of the
International Study Group on Innovative Insulin Delivery, Evian, France,
September 13-16.
2000
Issues
in comparisons between meta-analyses and large trials. Invited oral
presentation at the Joint Statistical Meetings, Indianapolis, Indiana, August
13-17.
2000 An
application of patient satisfaction in a multicenter randomized controlled
trial of inhaled insulin in subjects with type 1 diabetes mellitus. Invited
oral presentation at the 2000 International Chinese Statistical Association
Applied Statistics Symposium, Piscataway, New Jersey, June 1-3.
2000 Regulatory
issues for health-related quality of life: A report on a workshop. Invited oral
presentation at the Harvard/Schering-Plough conference on Measurement and
Analysis of Quality-of-Life Outcomes for Drug Development, Boston,
Massachusetts, June 1-2.
2000 Correlation
between subject self-assessment of erectile function and the erectile function
domain of the International Index of Erectile Function. Poster presentation at
the 2nd Annual Drug Information Association
Workshop on Pharmaceutical Outcomes Research, Seattle, Washington, May 11-12.
1999-2000 Large
trials vs meta-analysis of smaller trials: How do their results compare? Oral
seminar presentation, Yale University, New Haven, Connecticut, April 4, 2000;
invited oral presentation at the 1999 Joint Statistical Meetings, Baltimore,
Maryland, August 8-12, 1999; oral presentation at the Thirteenth New England
Statistics Symposium, Storrs, Connecticut, April 24, 1999.
1999 Development
and evaluation of the IIEF-5 as a diagnostic tool for erectile dysfunction.
Poster presentation at the 21st Annual Meeting of the Society for
Medical Decision Making, Reno, Nevada, October 3-6.
1999 Meta-analysis of therapeutic
trials. Oral presentation at the Pfizer-FDA Outcomes Research Preceptorship, Pfizer Inc, New York, NY, July 19-20.
1999 Analysis
issues in health-related quality of life. Oral (plenary) presentation from
break-out session at the 1999 Regulatory Issues in Health Related Quality of
Life Assessment: PhRMA/FDA Interactive Workshop, Washington, D.C., March 24-25.
1998 Validation of the
behavioural activity rating scale: A novel measure of activity in agitated
patients. Poster presentation at the 9th Congress of the Association of European Psychiatrists (AEP), Copenhagen,
Denmark, September 20-24.
1998 Viagra® (sildenafil citrate)
improves quality of life in erectile dysfunction. Poster presentation
at the 106th Annual Convention of the American Psychological Association, San
Francisco, California, August 14-18.
1998 Evaluating
the erectile function domain of the International Index of Erectile Function
(IIEF) as a diagnostic tool for erectile dysfunction. Invited oral presentation
at the Eighth Applied Statistics Symposium of the International Chinese
Statistical Association, Connecticut College, New London, Connecticut, June
5-7.
1998 Some
developments on the International Index of Erectile Function. Oral presentation
at the Drug Information Association workshop on Global Statistical Challenges
and Strategies in the Pharmaceutical Industry, Hilton Head, South Carolina,
March 15-17.
1997 Embedding the
regression-discontinuity within the randomized design in pharmacoeconomic
evaluations. Invited oral presentation at the session on Pharmacoeconomics at the 20th Midwestern
Biopharmaceutical Statistics Workshop, American
Statistical Association, at Ball State University, Muncie, Indiana, May 19-21.
1995 Statistical and clinical features
of cutoff designs. Invited presentation to the New York Chapter of the
American Statistical Association, New York, NY, September 14.
1995 Applying the “real-time
meta-analysis system” to randomized control trials of congestive heart failure. Oral presentation at
the 16th Annual Meeting of the Society for
Clinical Trials, Seattle, Washington, April 30-May 3.
1994 Relative efficiency of conventional
to cutoff-based randomized clinical trials.
Oral
presentation at the annual meeting of the American Evaluation Association,
Boston, Massachusetts, November 2-5.
1994 An
evaluation of large studies and meta-analyses of smaller studies. Oral plenary
presentation at the Second International Cochrane Colloquium, Hamilton,
Ontario, Canada, October 1-4.
1994 Comparing
results from the largest studies with meta-analyses of smaller studies. Oral
presentation at the 15th Annual Meeting of the Society for Clinical Trials,
Houston, Texas, May 8-11.
1994 Efficacy and safety of anticoagulant and
antiplatelet therapy versus anticoagulant therapy after heart valve replacement: A meta-analysis. Paper
presentation at the 15th Annual Meeting
of the Society for Clinical Trials, Houston, Texas, May 8-11.
1994 Efficacy and safety of different
aspirin dosages on vascular diseases: A meta- analysis. Poster presentation at the Meeting of
the American Federation for Clinical Research,
Baltimore, Maryland, April 29-May 2.
1993 Development
of a "Real-Time Meta-Analysis System (RTMAS)" to systematically
evaluate efficacy of ambulatory pharmaceuticals. Oral presentation at the
Dartmouth-Hitchcock Summer Symposium on Technology Assessment, Lyme, New
Hampshire, July 22-23.
1993 An introduction to WESVAR and
WESLOG for complex survey data in NIS-2. Oral presentation
at the 1993 Summer Research Institute, National Data Archive on Child Abuse & Neglect, Cornell University,
Ithaca, New York, July 11-16.
1993 The epidemiology of child sexual
abuse and physical abuse: Findings from the second incidence study. Oral
presentation at the Summer Research Institute, National Data Archive on
Child Abuse & Neglect, Cornell University, Ithaca, New York, July 11- 16.
1992 An illustrative statistical
analysis of cutoff-based randomized clinical trials. Oral presentation
at the 13th Annual Meeting of the Society for Clinical Trials, Philadelphia, Pennsylvania,
May 10-13.
1992 A review of the second national
incidence and prevalence study of child abuse and neglect. Oral presentation at the Judge Baker Children's
Center, Harvard Medical School,
Boston, Massachusetts, February 3.
1991 An
introduction to cutoff-based randomized clinical trials. Oral presentation at
the Harvard School of Public Health, Department of Epidemiology, Boston,
Massachusetts, October 23.
1991 Working with the second national
incidence and prevalence study of child abuse and neglect.
Workshop presentation at a skills workshop at the 9th Annual Conference on Child
Abuse & Neglect, Denver, Colorado, September 14.
1991 A simulation study of cutoff-based
randomized clinical trials. Oral seminar presentation at the 15th Meeting of the
Upstate New York and Southern Ontario Epidemiology Group,
State University of New York Health Science Center, Syracuse, New York, May 10.
1990 Random measurement error in
regression-discontinuity designs. Oral presentation at the American Evaluation Association
Conference, Washington, D.C., October 18-20.
1990 Power analysis of
regression-discontinuity designs. Paper presentation at the American
Evaluation Association Conference, Washington, D.C., October 18-20.
1990 Coupling the
regression-discontinuity design with the randomized experimental design: Computer
simulations from the UCSF cocaine treatment study. Oral seminar presentation at
Cornell University’s Epidemiology Forum, Ithaca, New York, March 30.
1990
Coupling outcome pattern matching and program theory with ordinal
categorical methods for the m by 2 ordered contingency table. Oral presentation
at the Edward F. Kelly Evaluation Conference, Ithaca, New York, February 23.
1989 Introduction to the regression-discontinuity
design in psychosocial epidemiology.
Oral
seminar presentation at Cornell University’s Epidemiology Forum, Ithaca,
New York, November 3.
2007 Health-related
quality of life and kidney cancer-related symptoms in patients with metastatic
renal cell carcinoma (mRCC0 treated with sunitinib versus interferon-alfa:
Results for the European and US subsample analyses in a randomized
multinational phase III trial. Cella D, Li JZ, Cappelleri JC, Bushmakin A,
Charbonneau C, Kim ST, Chen I, Motzer RJ. Poster presentation at the 14th
Meeting of the European Association for Cancer Research, Barcelona, Spain,
September 23-27, and at the 10th Annual European International
Society International Society for Pharmacoeconomics and Outcomes Research Congress, Dublin, Ireland, October 20-23,
2007.
2007 Quality of life (QOL) predicts for progression-free survival (PFS) in
patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib vs.
interferon-alfa (IFN-α). Cella D, Li JZ, Cappelleri JC, Bushmakin A,
Charbonneau C, Kim ST, Chen I, Michaelson MD, Motzer RJ. Poster presentation at
the 43rd Annual Meeting of the American Society of Clinical
Oncology, Chicago, Illinois, June 1-5.
2007 Effect of sildenafil on erectile function
and depression: Meta-analysis of randomized, double-blind, placebo-controlled studies
in men with erectile dysfunction and treated or untreated depression.
Cappelleri JC, Nurnberg HG, Siegel RL. Oral podium presentation at the the 160th
Annual Meeting of the American Psychiatric Association, San Diego, California,
May 19-24.
2007 Hypertension may not influence
cardiovascular benefits of statin therapy: Results from a meta-regression
analysis of 69,984 patients. Messerli FH, Pinto L, Tang S, Thakker KM,
Cappelleri JC, Dubois R. Poster presentation at the 12th Annual
International Meeting of the International Society for Pharmacoeconomics and
Outcomes Research, Arlington, Virginia, May 19-23.
2007 Health-related quality of life in
patients with metastatic renal cell carcinoma treated with axitinib
(AG-013736). Trask PC, Bushmakin AG, Cappelleri JC, Kim S, Bycott P, Liau KF.
Poster presentation at the 12th Annual International Meeting of the
International Society for Pharmacoeconomics and Outcomes Research, Arlington,
Virginia, May 19-23.
2007 Effects
of sunitinib versus interferon-alfa on health-related quality of life in
patients with metastatic renal cell carcinoma (mRCC). Cella D, Li JZ,
Cappelleri JC, Bushmakin A, Kim ST, Chen I, Motzer RJ. Oral presentation at the
22nd Annual European Association of Urology Congress, Berlin,
Germany, March 21-24.
2007 Effect of varenicline and bupropion on craving, nicotine
withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R, Baker CL, Cappelleri JC, Bushmakin A. Poster presentation at the 13th
Annual Meeting of the Society for Research on Nicotine and Tobacco, Austin,
Texas, February 21-24. Poster presentation at the UK National Smoking
Cessation Conference, London, England, June 14-15.
2006 Improved
depression severity by sildenafil treatment of erectile dysfunction associated
with treated or untreated major depressive disorder. Nurnberg GH, Siegel RL,
Cappelleri JC. Poster and oral presentation at the Sexual Medicine Society of
North America Fall Meeting, Las Vegas, Nevada, November 2-5.
2006 Impact
of five different methods of delivering a non-pharmacological weight loss
program on health related quality of life in patients on sibutramine. Bollu V,
Cappelleri JC, Bury-Maynard D, Gerber R, Digineo AG, Moritz W, Dvorak R. Poster
presentation at the North American
Association for the Study of Obesity 2006 Annual Scientific Meeting, Boston,
Massachusetts, October 20-24. Also, poster presentation at the 9th
Annual International Meeting of the International Society for Pharmacoeconomics
and Outcomes Research, Arlington, Virginia, May 16-19, 2004.
2006 Relationship between weight loss
expectations and actual weight loss in a randomized 6-month weight loss study.
Bollu V, Cappelleri JC, Bury-Maynard D, Gerber R, Digineo AG, Moritz W, Dvorak
R. Poster presentation at the North American Association for the Study of
Obesity 2006 Annual Scientific Meeting, Boston, an Association for the Study of
Obesity 2006 Annual Scientific Meeting, Boston, Massachusetts, October 20-24.
2006 How cognitive function
affects activities of daily living in patients with Alzheimer’s Disease. Treglia M, Bushmakin A, Siddiqi S,
Cappelleri JC. Poster presentation at the 22nd Conference of Alzheimer’s Disease International,
Berlin, Germany, October 12-14. Also presented as a poster presentation at the 9th Annual International
Meeting of the International Society for Pharmacoeconomics and Outcomes
Research, Arlington, Virginia, May 16-19, 2004.
2006 A comparison of two confidence interval approaches on
the dependability coefficient in a two-factor crossed design. Cappelleri JC,
Ting N. Oral presentation at the Joint Statistical Meetings, Seattle, Washington,
August 6-10.
2006 Does
the presence of hypertension affect cardiovascular benefits of statin therapy?
Results from a meta-regression analysis of 69,984 patients. Messerli FH, Pinto
L, Tang S, Thakker KM, Cappelleri JC, Sichrovsky T, Dubois R. Poster
presentation delivered at the 55th Annual Scientific Sessions of the
American College of Cardiology, Atlanta, Georgia, March 11-14; oral
presentation delivered at the Sixteenth European Society of Hypertension,
Madrid, Spain, June 12-15, 2006.
2006 Mayo
Clinic/FDA Patient-reported Outcomes Consensus Meeting Group. Five invited oral
plenary presentations and draft manuscripts on conceptual issues; instrument
selection; development issues; validation; and analysis, interpretation and
reporting of results presented at the Mayo Clinic/FDA meeting on
the FDA Guidance on Patient Reported Outcomes, Chantilly, Virginia, February
23-25.
2005 The International Index of Erectile
Function (IIEF): an industry-based, brief sexual scale. Rosen RC, Cappelleri
JC. Invited oral and paper presentation delivered at the European Medicines
Agency Workshop, London, England, October 21.
2005 Establishing a minimally important difference in
6-minute walk distance and SF-36 among patients with pulmonary arterial
hypertension. Gilbert C, Brown, MCJ, Cappelleri JC, Parpia T, and McKenna SP on
behalf of the SUPER-1 Study group. Poster presentation delivered at the Annual
Congress of the American College of Chest Physicians, Montreal, Canada, October
29-November 3.
2005 Reliability, validity, and
responsiveness of the QIDS-SR-16 daily version. Lenderking WR, Hu M, Cappelleri
JC, Rush AJ. Poster presentation at the 12th Annual Meeting of the
International Society for Quality of Life Research, San Francisco, California,
October 19-22.
2005 Development
and evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A)
scale
for measurement of onset of symptom relieve in patients with GAD. Williams V,
Morlock R,
Fehnel S, Wills M, Hill C, Barrows S, Cappelleri JC, Feltner D. Poster
presentation at the 12th Annual Meeting of the International Society
for Quality of Life Research, San Francisco, California, October 19-22.
2005 Perioperative myocardial ischemic injury:
Incidence and resource utilization in prospective clinical trial. Mackey WC,
Fleisher LA, Haider S, Sheikh S, Cappelleri JC, Lee WC, Wang Q, Stephens J.
Oral presentation at 2005 Annual Meeting of the New England Society for
Vascular Surgery, Stowe, Vermont, September 16-18.
2005 Evaluating the sample invariance
property of the standard error of measurement. Ghosh S, Cappelleri J, Bushmakin
A, Lenderking WR. Oral presentation at the Joint Statistical Meetings,
Minneapolis, Minnesota, August 7-11.
2005 Near normalization of erectile
function and improvement of psychosocial quality of life in men with erectile
dysfunction treated with sildenafil citrate. Stecher VJ, Levinson IP, Cappelleri JC, Siegel RL, Tseng L-J. Poster
presentation at the 100th Annual Meeting of the American Urological
Association, San Antonio, Texas, May 21-26.
2005 Linking
changes in visual functioning according to changes in visual acuity among
patients with age-related macular degeneration. Pleil AM, Cappelleri JC,
Thompson JR, Getter CA, Li SC, Coleman R, Chikkala S, Knur K, Reichel MB, Wolf
S. Poster presentation at the annual meeting of the Association for Research in
Vision and Ophthalmology, Fort Lauderdale, Florida, May 1-5.
2005 Cross-sectional
and longitudinal assessments of the 25-item National Eye Institute Visual
Function Questionnaire in patients with age-related macular degeneration.
Reichel MB, Wolf S, Cappelleri JC, Thompson JR, Getter CA, Li SC, Coleman R,
Chikkala S, Knur K, Pleil AM. Poster presentation at the annual meeting of the
Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida,
May 1-5.
2005 Self-esteem and erectile function
after 9 months of sildenafil citrate treatment. Althof SE, O’Leary MP,
Cappelleri JC, Siegel RL, Crowley AR, Harnett J, Tseng L-J. Collins S. Poster
presentation at the 30th Annual Conference of the American Society
of Andrology, Seattle, Washington, April 2-5, 2005.
2005 Evaluation
of the Daily Assessment of Symptoms-Anxiety (DAS-A) Questionnaire in patients
with generalized anxiety disorder. Morlock R, Williams V, Feltner D, Cappelleri
JC, Brock J, Endicott J. Poster presentation at the 25th Annual
Conference of the American Disorders Association of America, Seattle,
Washington, March 17-20. Poster presentation at the 158th Annual
Meeting of the American Psychiatric Association, Atlanta, Georgia, May 21-26.
2005 Clinical evaluation of the Daily
Assessment of Symptoms-Anxiety (DAS-A): A new instrument to assess the onset of
efficacy in Generalized Anxiety Disorder (GAD). Feltner D, Harness J, Brock J,
Sambunaris A, Cappelleri J, Morlock R. Poster presentation at the 25th
Annual Conference of the American Disorders Association of America, Seattle,
Washington, March 17-20.
2004 Using
a pattern mixture model to understand the impact of nonrandom missing data in
health-related quality of life among patients undergoing non-cardiac vascular
surgery. Lee WC, Cappelleri JC, Haider S, Sheikh S, Gold K, Stephens J. Poster
presentation at the International Society of Pharmacoeconomics and Outcomes
Research 7th Annual European Congress, Hamburg, Germany, October
24-26.
2004 Relationship between erectile
functioning and psychosocial functioning following treatment with Viagraâ
(sildenafil citrate): Results from an international, multicenter, randomized,
double-blind, placebo-controlled trial. Glina
S, Cappelleri JC, Duttagupta S, Sherman N, Stecher VJ, Siegel R, Tseng L-J. Podium
presentation at the 11th World Congress of the International Society
for Sexual and Impotence Research, Buenos Aires, Argentina, October 17-21.
2004 Relationship between erectile
functioning and psychosocial functioning following treatment with Viagraâ
(sildenafil citrate): Results from an international trial. Takei M, Takamoto H,
Glina S, Cappelleri JC, Duttagupta S, Sherman N, Stecher VJ, Siegel R, Tseng
L-J. Poster presentation at the 11th Annual Meeting of the
International Society for Quality of Life Research, Hong Kong, China, October
16-19.
2004 Assessing self-esteem, confidence,
and relationships in men with erectile dysfunction treated with Viagraâ (sildenafil citrate):
Results form an international, multicenter, double-blind, placebo-controlled
trial. King R, Glina S, Cappelleri JC, Duttagupta S, Sherman N, Stecher VJ,
Siegel R, Tseng L-J. Moderated poster presentation at the Société
Internationale d’Urologie. Honolulu, Hawaii, October 3-7.
2004 Daily
measurement detects an earlier onset antidepressant effect. Lenderking WR, Hu M,
Tennen H, Cappelleri JC, Petrie CD. Oral presentation at the
International Society for Quality
of Life Research 2004 Symposium, Boston, MA, June 27-29.
2004 Applying
the Rasch model to enhance interpretation of the National Eye Institute Visual Functioning
Questionnaire. Thompson JR, Cappelleri JC. Poster presentation at the Drug Information Association/National Cancer
Institute conference on “Advances in Health Outcomes Measurement: Exploring
the Current State and the Future Applications of Item Response
Theory, Item Banks, and Computer-adaptive Testing,” Bethesda, Maryland, June
24-25.
2004 Relationship
between erectile functioning and psychosocial functioning following treatment
with sildenafil citrate: Results from a multicenter, double-blind,
placebo-controlled trial. Forest C, Althof SE, O’Leary M, Cappelleri JC.
Poster presentation at the 32nd Annual Conference of the American
Academy of Physician Assistants, Las Vegas, Nevada, June 1-6.
2004 Health
status in high-risk patients undergoing noncardiac vascular surgery in the
United States. Sheikh S, Haider S, Cappelleri JC, Lee WC, Gold K, Stephens J,
Fleisher LA. Poster presentation at the 9th Annual International
Meeting of the International Society for Pharmacoeconomics and Outcomes
Research, Arlington, Virginia, May 16-19.
2004 Comparing
psychometric properties of self-versus interviewer-rated instruments used in
clinical trials for patients with anxiety disorders. Lau DT, Cappelleri
JC, Morlock R, Feltner D. Poster
presentation at the 9th Annual International Meeting of the
International Society for Pharmacoeconomics and Outcomes Research, Arlington,
Virginia, May 16-19.
2004 A
meta-analysis of three-day azithromycin therapy versus longer courses of
comparator antibiotics in acute sinusitis. Harnett J, Enuha S, Xuan J,
Cappelleri JC. Poster presentation at the 9th Annual International
Meeting of the International Society for Pharmacoeconomics and Outcomes
Research, Arlington, Virginia, May 16-19.
2004 Assessing
onset of symptom relief in patients with generalized anxiety disorder. Morlock
R, Feltner D, Fehnel S, Williams V, Cappelleri J, Harness J, Kavoussi R,
Endicott J.
Poster
presentation at the 157th Annual Meeting of the American Psychiatric
Association, New York, New York, May 1-6, and at the 24th Annual
Conference of the Anxiety Disorders Association of America, Miami, Florida,
March 11-14.
2004 Assessing
self-esteem, confidence, and relationships in men with erectile dysfunction
treated with sildenafil citrate: Results from an international, multicenter,
double-blind placebo-controlled trial. Stecher VJ, Glina S, Cappelleri JC, Duttagupta S,
Sherman N, Siegel R, Tseng L-J. Poster presentation at the 157th Annual Meeting of the
American Psychiatric Association, New York, New York, May 1-6.
2004 US
double-blind, placebo-controlled trial assessing self-esteem, confidence, and
relationships in men with erectile dysfunction treated with sildenafil citrate.
Althof SE, Cappelleri JC, Duttagupta S, Sherman N, Siegel R, Crowley AR, Tseng
L-J. Poster presentation at the 157th Annual Meeting of the American
Psychiatric Association, New York, New York, May 1-6.
2004 Quality
of life in patients with occult choroidal neovascularisation: A three-year
longitudinal study. Gäbler P, Pleul C, Reichel
C, Knur K, Nestler A, Lustig S, Cappelleri JC, Wolf S, Reichel MB. Poster presentation at the annual meeting
of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, April 25-29.
2004 Health-related
quality of life compared with visual function and lesion size in patients with
age-related macular degeneration. Knur KK,
Gäbler P, Lustig S, Cappelleri JC, Wolf S, Reichel MB. Poster presentation at the annual meeting
of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, April 25-29.
2004 Age-related
macular degeneration and health care resource utilization in a one-year
longitudinal study. Pleul C, Gäbler P, Lustig
S, Cappelleri JC, Wolf S, Reichel MB. Poster
presentation at the annual meeting of the Association for
Research in Vision and Ophthalmology,
Fort Lauderdale, Florida, April 25-29.
2004 Quality
of life in patients with age-related macular degeneration: A prospective study.
Knur KK, Reichel MB, Gäbler P, Pleul C, Getter C, Lustig S, Cappelleri JC,
Wolf S. Poster presentation at the annual meeting of the Association for
Research in Vision and Ophthalmology, Fort Lauderdale, Florida, April 25-29.
2004 An
interpretation of quality of life based on binocular visual acuity in German
patients with age-related macular degeneration. Pleil AM, Cappelleri JC,
Chisholm JA, Getter CA, Lustig SP, Reichel MB. Poster presentation at the annual meeting of the Association
for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, April
25-29.
2004 Validity
and reliability of the German version of the 25-item National Eye Institute
Visual Function Questionnaire in patients with age-related macular degeneration.
Lustig SP,
Cappelleri JC, Chisholm JA, Getter CA, Pleil AM, Reichel MB. Poster presentation at the annual meeting
of the Association for Research in Vision and Ophthalmology, Fort Lauderdale,
Florida, April 25-29.
2004 Responsiveness
of the Self-Esteem And Relationship questionnaire in men with erectile
dysfunction treated with Viagra® (sildenafil citrate): Results
from an international, double-blind, placebo-controlled trial. Glina S, Cappelleri JC,
Duttagupta S, Sherman N, Stecher VJ, Siegel R, Tseng L-J. Poster presentation at the European
Association of Urology, 19th Annual Congress, Vienna, Austria, March
24-27.
2003 Health-related
quality of life compared with visual function and lesion size in patients with
age-related macular degeneration. Knur KK, Reichel MB, Gäbler P, Lustig S,
Cappelleri JC, Wolf S. Poster presentation at the European Association for
Vision and Eye Research, Alicante, Spain, October 8-11.
2003 Health-care resource utilization in
patients with age-related macular degeneration in a one-year longitudinal
study. Pleul C, Reichel MB, Gäbler P, Lustig S, Cappelleri JC, Wolf S.
Poster presentation at the European Association for Vision and Eye Research,
Alicante, Spain, October 8-11.
2003
Relationship of satisfactory sexual
intercourse and psychosocial factors following Viagra®
(sildenafil citrate) treatment in men with erectile dysfunction. Althof SE,
Cappelleri JC, Duttagupta S, Stecher V. Poster presentation at the
International Consultation on Erectile and Sexual Dysfunctions, Paris, France,
June 28-July 1.
2003 Assessing
behavioral functioning in Alzheimer’s disease: Benchmarking with the
BEHAVE-AD-FW. Treglia M, Clouse B, Cappelleri JC. Poster presentation at the 8th
Annual International Meeting of the International Society for Pharmacoeconomics
and Outcomes Research, Arlington, Virginia, May 18-21.
2003 Long-term
treatment satisfaction with inhale insulin (Exubera®) and
improved glycemic control in patients with type 1 and type 2 diabetes. Rosenstock J, Cappelleri
JC, Nadkarni S, Petrie CD, Gerber RA. Poster presentation at the Twelfth Annual Meeting of the American
Association of Clinical Endocrinologists, San Diego, California, May 14-18.
2003 A two
year longitudinal study of quality of life in patients with occult choroidal
neovascularisation. Gäbler P, Pleul C,
Nössler N, Knur K, Nestler A, Lustig S, Cappelleri J, Wolf S, Reichel MB. Poster presentation at the annual meeting
of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 4-May 9.
2003 Health-related
quality of life measured by the NEI-VFQ in 300 patients with age-related
macular degeneration. Reichel MB, Knur K, , Pleul C, Reichel CM, Nestler A,
Lustig S, Cappelleri J, Wolf S. Poster presentation
at the annual meeting of the Association for Research in Vision and
Ophthalmology, Fort Lauderdale, Florida,
May 4-May 9.
2003 Confidence
intervals on intraclass correlation coefficients in a balanced two-factor
random design. Gilder K, Ting N, Cappelleri JC, Hanamura RC. Oral presentation
at the First Annual Connecticut ASA Statistics Mini-Conference, Stamford,
Connecticut, May 3.
men with
erectile dysfunction treated with sildenafil citrate. O’Leary M,
Cappelleri JC, Shpilsky AB, Duttagupta S, Siegel R, Althof SE. Poster
presentation at the
American
Urological Association Annual Meeting, Chicago, Illinois, April 26-May 1.
2003 A modified large sample approach to approximate
interval estimation for a certain intraclass correlation coefficient.
Cappelleri JC, Ting N. Oral presentation at the San Diego chapter of the
American Statistical Association, San Diego, California, April 17.
2002-3 Assessing
clinical significance for QOL measures in oncology research. Berzon R, Sloan J,
Varricchio C. Oral presentation at the Canadian Association for Psychosocial
Oncology/6th World Congress of Psycho-Oncology, Banff, Alberta,
Canada, April 23-27, 2003; Frost M, Osoba D, Sloan J, Berzon R. Oral presentation
at the 38th Annual Meeting of the Drug Information Association,
Chicago, Illinois, June 16-20, 2002.
2002
Self-esteem in patients with erectile dysfunction: An important but
overlooked parameter in measuring treatment effectiveness. Bell S, Cappelleri
JC, Duttagupta S. Poster presentation at the Fourth Annual Drug Information
Association Workshop on Pharmaceutical Outcomes Research, Newport, Rhode
Island, October 16-18.
2002 Balancing
compliance, patient satisfaction and improved glycaemic control in patients
with type 1 and type 2 diabetes: Long-term studies with inhaled insulin
(Exubera®). Rosenstock J, Cappelleri JC, Nadkarni S, Petrie CD,
Gerber RA. Poster
presentation at the 38th Annual Meeting of the European Association
for the Study of Diabetes, Budapest, Hungary, September 1-5.
2002 Development
and validation of Self-Esteem/Overall Relationship Questionnaire (SEORQ) in
erectile dysfunction. Cappelleri JC, Bell SS, Stecher V, Diuguid C, Duttagupta
S, Sweeney M, Quirk F. Poster presentation at the 18th International
Conference on Pharmacoepidemiology, Edinburgh, Scotland, August 18-21.
2002 Assessing
the clinical significance of single items relative to summated scores. Sloan
JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C, for the Clinical
Significance Consensus Meeting Group. Poster presentation at the American
Society of Clinical Oncology, Orlando, Florida, May 18-21.
2002 A 12
month longitudinal study of health related quality of life in patients with
occult choroidal neovascularisation. Reichel MB, Gäbler P, Nössler N,
Pleul C, Nestler A, Reichel
C, Lustig S, Cappelleri J, Wolf S. Oral presentation
at the annual meeting of the Association for Research in Vision and
Ophthalmology, Fort Lauderdale, Florida,
May 5-May 10.
2001 Relacion entre la mayor
satisfaccion del paciente con insulina inhalada y un mejor control glicemico en
pacientes con diabetes tipo 1 o tipo 2. Rosenstock J, Cefalu W, Skyler J, Gerber RA, Cappelleri JC, Nadkarni
S, Petrie CD, Kourides IA. Poster presentation at the
XI Congreso Asociacion Latinoamericana de Diabetes (ALAD), Uruguay,
November 11-15;
Improved
patient satisfaction is associated with inhaled insulin and improved glycemic
control: Results from two multi-center randomized controlled trials. Cappelleri
JC, Gerber RA, Rosenstock J, Nadkarni S, Petrie CD, Kourides IA. Poster presentation at the American Diabetes
Association’s 61st Scientific Sessions. Philadelphia,
Pennsylvania, June 22-26.
2000-1 The WOMAC discriminates between patients with mild and
severe osteoarthritis. Lustig SP,
Shaw AR, Cappelleri JC, Vazquez-Abad M-D. Poster
presentations at
64th Annual Scientific
Meeting of the American College of Rheumatology and 35th Annual
Scientific Meeting of the Association of Rheumatology Health Professionals,
Philadelphia, Pennsylvania, October 28-November 2, 2000.
3rd Annual Drug Information
Association (DIA) Workshop on Pharmaceutical Outcomes Research, Savannah,
Georgia, April 22-24, 2001.
2000 Differences in information processing speed deficits
between subtypes of multiple sclerosis. Snyder PJ, Cappelleri JC,
Archibald CJ, Fisk JD. Poster presentation at the 30th Annual Meeting of the
Society for Neuroscience, New Orleans, Louisiana, November 4-9.
2000 Relationship
between changes in joint space width (JSW) and C-reactive protein (CRP),
clinical assessments, and health-related quality of life (HRQoL) instruments in
mild/moderate osteoarthritis (OA). Woodworth TG, Mackillop N, Edwards M,
Vazquez-Abad M-D, Shaw AR, Cappelleri JC, Ting N, Buckland-Wright C, Lustig S.
Poster presentation at the 64th Annual Scientific Meeting of the
American College of Rheumatology and 35th Annual Scientific Meeting
of the Association of Rheumatology Health Professionals, Philadelphia,
Pennsylvania, October 28-November 2.
2000 Improved
patient satisfaction with inhaled insulin in subjects with type 2 diabetes
mellitus: Results from a multicenter randomized controlled trial. Cappelleri
JC, Gerber RA, Bell-Farrow AD, English JS, Agramonte RF, Kourides IA.
Poster presentation at the American Diabetes Association’s 60th
Scientific Sessions, San Antonio, Texas, June 9-13.
2000 Improved
patient satisfaction with inhaled insulin in subjects with type 1 diabetes
mellitus after one year: Results from a multicenter extension trial. Gerber RA,
Cappelleri JC, Bell-Farrow AD, English JS, Agramonte RF, Gelfand RA.
Poster presentation at the American Diabetes Association’s 60th
Scientific Sessions, San Antonio, Texas, June 9-13.
2000 Information processing speed
deficits may be better correlated with the extent of white matter sclerotic
lesions in multiple sclerosis than previously suspected. Snyder PJ, Cappelleri
JC. Poster presentation at the Eleventh Annual Meeting of Theoretical &
Experimental Neuropsychology (Tennet XI), Université du Québec
à Montréal, Montréal, Canada, June 15-17.
1999 A diagnostic evaluation of the
erectile function domain of the International Index of Erectile Function
(IIEF). Sweeney M, Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Poster
presentation at the First International Consultation on Erectile Dysfunction,
Paris, France, July 1-3.
1999 Subanalysis of the
efficacy of Viagraâ (sildenafil citrate) in the treatment of mild erectile dysfunction.
Stecher V, Sweeney M, Cappelleri JC, Smith MD. Poster presentation at the First
International Consultation on Erectile Dysfunction, Paris, France, July 1-3. Poster presentation at the V Congreso de la
Sociedad Latino Americana Para El Estudio de la Impotencia (SLAI), Acapulco,
Mexico, October 7-10.
1999 Improved
patient satisfaction with inhaled insulin in subjects with type 1 diabetes
mellitus: Results from a multicenter randomized controlled trial. Gerber RA,
Cappelleri JC, Kourides IA, Gelfand RA, Chandler LP, Gorkin L. Oral presentation
at the 59th Annual Scientific Meeting of the American Diabetes
Association, San Diego, California, June 19-22.
1998 Constructing and evaluating the
“Sexual Health Inventory for Men: IIEF-5” as a diagnostic
tool for erectile dysfunction. Rosen RC, Cappelleri JC, Smith MD, Lipsky J,
Peña, B. Oral presentations at
8th
World Meeting for Impotence Research, Amsterdam, Holland, August 25-28.
4th
Asian Congress in Urology, Singapore, September 17-20 (with Y. Kimoto).
1998 Validation of the behavioural
activity rating scale: A novel measure of activity in agitated patients. Swift RH,
Harrigan EP, Cappelleri J, Kramer D, Chandler LP.
Poster
presentations at
11th European College of
Psychopharmacology (ECNP), Paris, France, October 31-November 4.
21st Collegium Internationale
Neuro-Psychopharmacologicum (CINP) Glasgow, Scotland, July 12-16.
151st
Annual Meeting of the American Psychiatric Association (APA)
Toronto,
Canada, May 30-June 4.
1998 Weight gain associated with
conventional and newer antipsychotics: A meta-analysis.
Allison DB, Mentore JL, Heo M, Weiden P, Cappelleri J,
Chandler LP.
Poster
presentations at
151st
Annual Meeting of the American Psychiatric Association (APA) Toronto,
Canada, May 30-June 4.
9th
Congress of the Association of European Psychiatrists (AEP) Copenhagen,
Denmark, September 20-24.
1998 Issues
in comparisons between meta-analyses and large trials. Ioannidis, JPA,
Cappelleri, JC, Lau, J. Oral presentation at the 19th Annual Meeting
at the Society for Clinical Trials, Atlanta, Georgia, May 17-20.
1997 Interaction of epidemic and
individual heterogeneity on target populations of clinical trials.
Ioannidis JPA, Cappelleri JC, Schmid CH, Lau J. Poster presentation at the Second
Joint
Society for Clinical Trials and International Society for Clinical
Biostatistics, Boston,
Massachusetts, July 6-10.
1997 An empirical study of the effect of
the control rate as a predictor of treatment efficacy in meta-analysis
of clinical trials. Schmid CH, Lau J, McIntosh MW, Cappelleri JC. Invited oral presentation at
the International Conference on Health Policy Research: Methodological Issues in Health
Services and Outcomes Research, Washington, D.C., December 5-7.
1990 Cutoff assignment strategies for
enhancing randomized clinical trials (RCTs). Trochim WMK, Cappelleri JC. Oral
presentation at the Annual Conference of the American Evaluation Association,
Washington, D.C., October 18-20.
1990 Why
Stanley and Robinson are wrong again about the regression-discontinuity design.
Trochim WMK, Cappelleri JC. Oral presentation at the Annual Conference of
the American Evaluation Association, Washington, D.C., October 18-20.
Other Professional Contributions
Co-chair
and co-organizer. 7th International Conference on Health Policy
Statistics: Methodological Issues in Health Services and Outcomes Research, Philadelphia,
Pennsylvania, January 25-26, 2008.
Member, Executive
Committee, Health Policy Statistics Section, American Statistical Association,
2006-2008.
Organizer of contributed session. Advances in confidence
intervals on variance components.
Joint Statistical Meetings, Seattle, Washington, August 6-10, 2006.
Member
(2006-2008). Committee on Outreach Education, American Statistical Association.
Course
Faculty. Mayo Clinic College of Medicine. FDA Guidance on Patient Reported:
Discussion, Dissemination, and Operationalization, Chantilly, Virginia,
February 23-25, 2006.
Organizer and chairperson of invited session. Developments
in meta-analysis. 15th Annual Applied Statistics
Symposium of the International Chinese Statistical Association, Storrs,
Connecticut, June 14-17, 2006.
Chairperson of invited
session. Predicting high-cost users of medical care and persistence of high
expenditures over time. 6th International Conference on Health
Policy Research: Methodological Issues in Health Services and Outcomes Research, Boston,
Massachusetts, October 28-30, 2005.
Member
of Scientific Planning Committee. 6th International Conference on
Health Policy Research: Methodological Issues in Health Services and Outcomes
Research, Boston, Massachusetts, October 28-30, 2005.
Host/Organizer. Longitudinal
research: Current status and future prospects. Two-hour workshop by Judith
Singer and John Willett, Groton, CT, August 26, 2005.
Host/Speaker. Longitudinal
data: Basic concepts. Joint Statistical Meetings, Health Policy Statistics
Session Roundtable Luncheon, Minneapolis, Minnesota, August 7-11, 2005.
Workshop
leader. Use pharmacoeconomics and patient reported outcomes (PROs) to
demonstrate product value in Phase IV studies. Invited workshop presentation at the Center for
Business Intelligence’s 5th Annual Forum on Phase IV Clinical
Trials, Philadelphia, Pennsylvania, September 20-21, 2004.
Chairperson of invited session. Advanced statistical analysis I. International Society for Quality of Life Research
2004 Symposium - Stating the art: Advancing outcomes research methodology and
clinical applications, Boston, Massachusetts, June 27-29, 2004.
Statistical
consultant and member of scientific advisory board (January 1, 2004 to
present). Child and Adolescent Trauma Treatments and Services Project (CATS).
Led and managed by the New York State Office of Mental Health.
Organizer of
invited session. Advances in meta-analysis. Joint Statistical Meetings,
Toronto, Canada, August 8-12, 2004.
Host/Speaker.
Generalizability theory. Joint Statistical Meetings, Health Policy Statistics
Session Roundtable Luncheon, Toronto, Canada, August 8-12, 2004.
Staff representative. Joint Council of Sections/Council of Chapters
Information Booth, Joint
Statistical Meetings, Toronto, Canada, August 8-12, 2004.
Reviewer of
abstracts. International Society for Quality of Life Research 2004 Symposium -
Stating the art: Advancing outcomes research methodology and clinical
applications, Boston, Massachusetts, June 27-29, 2004.
Member of the ISOQOL Scientific Program Committee. Stating the art: Advancing outcomes
research methodology and clinical applications, International Society for
Quality of Life Research 2004 Symposium, Boston, Massachusetts, June 27-29,
2004.
Reviewer of
abstracts. International Society for Pharmacoeconomics and Outcomes Research 9th
Annual International Meeting, Arlington, Virginia, May 16-19, 2004.
Representative
to the Council of Sections (2002-2004). Executive Committee, Health Policy
Statistics Section, American Statistical Association.
Chairperson. Quality of life and measurement. International Conference on Health Policy Research: Methodological Issues
in Health Services and Outcomes Research, Chicago, Illinois, October 17-19,
2003.
Pfizer representative. Support for student travel at the 2003
International Conference on Health Policy Research, Chicago, Illinois, October
17-19, 2003.
Course Faculty. Mayo Clinic College of Medicine. Quality of Life III:
Translating the Science of QOL Assessment into Clinical Practice, Scottsdale,
Arizona, October 2-4, 2003.
Reviewer of abstracts. Tenth Annual Meeting of the International Society
for Quality of Life Research, Prague, Czech Republic, November 12-15, 2003.
Host/Speaker.
Methods to explain clinical significance of health status measures. Joint
Statistical Meetings, Health Policy Statistics Session Roundtable Luncheon, San
Francisco, California, August 3-7, 2003.
Judge. Poster session. Eight Annual International Meeting
of the International Society for Pharmacoeconomics and Outcomes Research,
Arlington, Virginia, May 18-21, 2003.
Moderator. Contributed podium presentations on cardiovascular disease. Eight
Annual International Meeting of the International Society for Pharmacoeconomics
and Outcomes Research, Arlington, Virginia, May 18-21, 2003.
Chairperson. Paper session on clinical significance. Ninth Annual Conference of the International
Society for Quality of Life Research, Orlando, Florida, October 30-November 2,
2002.
Judge of the
Early Career Investigator Best Poster Awards. Ninth Annual Conference of the
International Society for Quality of Life Research, Orlando, Florida, October
30-November 2, 2002.
Member of the ISOQOL Scientific Program Committee.
Ninth Annual Conference of the International Society for Quality of Life
Research, Orlando, Florida, October 30-November 2, 2002.
Health Outcomes
Committee, Pharmaceutical Research and Manufacturers of America (PhRMA),
Technical advisor (ad hoc). Health Outcomes Committee, 1999-present.
Staff
representative. Joint Council of Sections/Council of Chapters Information
Booth, Joint Statistical
Meetings, New York, NY, August 11-15, 2002.
Organizer of roundtables.
American Statistical Association, Biopharmaceutical Section, Joint Statistical
Meetings, New York, NY, August 11-15, 2002.
Member. Organizing Committee of the Mathematical Sciences Research Institute's
Symposium and Workshop: Statistical Challenges for Meta-analysis of Medical and
Health-policy Data, Berkeley, California, May 9-11, 2002.
Reviewer of abstracts. Seventh Annual International
Meeting of the International Society for Pharmacoeconomics and Outcomes
Research, Arlington, Virginia, May 19-22, 2002.
Coordinator.
Submitted listing calendar events of 1st (2000), 2nd
(2001), 3rd (2002), 4th (2003), 5th (2004),
and 6th (2005) Kitasato
University-Harvard School of Public Health Symposium in Amstat News.
Course Faculty. Mayo Clinic
College of Medicine. Assessing Clinical Significance for Quality of Life
Measures in Oncology Research: State-of-the-Science, Rochester, Minnesota,
April 5-6, 2002.
Thesis or
graduate coadvisor. Samiran Ghosh (University of Connecticut, 2006); Fang Reng
(University of Connecticut, 2004); Kye Gilder (University of Rhode Island,
2003); Mark Unruh (Tufts University, 2002); and Suzanne Vogel (Yale University,
2000).
Chairperson.
Risk adjustment and provider profiling. International
Conference on Health Policy Research: Methodological Issues in Health Services
and Outcomes Research, Boston, Massachusetts, December 7-9, 2001.
Reviewer of abstracts. Eighth Annual Conference of the
International Society for Quality of Life Research, Amsterdam, The Netherlands,
November 7-10, 2001.
Moderator/Organizer.
Frontiers in meta-analysis. Sixth Annual International Meeting of the
International Society for Pharmacoeconomics and Outcomes Research, Arlington,
Virginia, May 20-23, 2001.
Host/Speaker.
Analyzing resources and cost data from randomized trials. Joint Statistical
Meetings, Biopharmaceutical Session Roundtable Luncheon, Indianapolis, Indiana,
August 13-17, 2000.
Organizer
of invited session. Methodological issues in meta-analysis. Joint Statistical
Meetings, Indianapolis, Indiana, August 13-17, 2000.
Reviewer.
LogXact 4 for Windows: Logistic Regression Software Featuring Exact methods
(Cambridge, MA: Cytel Software Corporation, 2000), by Cyrus Mehta and Nitin
Patel.
Reviewer.
Comprehensive Meta-analysis: A Computer Program for Research Synthesis
(Englewood, NJ: Biostat, 1999), by Michael Borenstein and Hannah Rothstein.
Reviewer. SOLAS™
2.0 for Missing Data (Cork, Ireland: Statistical Solutions Ltd., 1999).
Chairperson.
Analysis issues in health-related quality of life. 1999 Regulatory Issues in
Health Related Quality of Life Assessment (PhRMA/FDA Workshop), Washington,
D.C., March 24-25, 1999.
Chairperson/Organizer
of invited session. Outcomes research issues in Alzheimer’s disease.
PhRMA Biostatistics and Clinical Data Management 1998 Annual Workshop:
Opportunity and Challenges for Industry and FDA, Bethesda, Maryland, November 9-11,
1998.
Chairperson/Organizer of invited session.
Eighth Applied Statistics Symposium of the International Chinese Statistical
Association, Connecticut College, New London, Connecticut, June 5-7, 1998.
Chairperson/Organizer of invited session. Randomized
controlled trials and outcomes research. Drug Information Association meeting
on Global Statistical Challenges and Strategies in the Pharmaceutical Industry,
Hilton Head, South Carolina, March 15-17, 1998.
Pfizer representative. Honorary dinner committee
representing Pfizer at Rise to the Occasion, a fundraising gala to raise
research funds for the American Paralysis Association, Hartford, Connecticut,
May 2, 1998.